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Abstract 
Aim and applications 
• Optimize fluorescence-based cellular assays for getting insights about mechanisms 
leading to cell death. 
• Informative high content assays development with the aim to implement them in order 
to obtain preliminary toxicity information of compounds. 
• Toxicity profiling of chemicals or biologicals used in screening, in particular hits 
behavior relative to the characterization of cell viability. 
 
Methods 
Different fluorescent probes for cell viability were tested and optimized in HeLa cells by 
varying parameters of staining, controls and incubation times. Automated fluorescence 
microscopy was used to image cells in 96-well plates and automated image analysis provided 
tool for quantification of the response to the different assays. Image quality was estimated in 
each condition and ability to discriminate between positive and negative populations was 
statistically determined after image segmentation and features extraction. 
 
Results 
Live/dead assay using calcein-AM and ethidium homodimer-1 showed significant difference 
in signal between living and dead cells but high variability was observed within the same 
population. Apoptosis probes FLICA and annexin V conjugate were tested on cells treated 
with staurosporine. FLICA staining gave low signal-to-background ratio and apoptotic 
population was not significantly discernible. Living, early apoptotic and necrotic/late 
apoptotic cells populations were segregated using annexin V assay. Autophagy detection 
using LC3B immunostaining was observable in cells treated with chloroquine. Developed 
image analysis method reliably segmented autophagosomes in autophagic cells but failed with 
dead cells. Assays were tested on a set of toxic compounds and results showed differences 
with information found on these substances.  
 
Conclusion 
Fluorescent probes are a powerful tool to assess cell death mechanism in high content 
screening assay as they can report multiple biological activities at the same time. As 
information in this type of assay are gathered at a single cell level, high variability is expected 
and must be reduced as possible to successfully characterize the phenotypes encountered and 
reach screening requirements. 
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1. Introduction 
1.1. High content image-based screening 
Drug discovery is the process by which a molecule is found to have a biological effect against 
a disease in an organism. During the past years, scientists have developed automated 
equipments that allow performing a consequent number of parallel experiments in a time that 
can never be achieved by manual manipulations. This automation process and the fact that 
multiple compounds are tested at the same time are called high throughput screening (HTS). 
During a screen, the activity of each compound is reported by an assay that quantitatively 
determines the potency of the molecule on the target effect. The assay read out can take 
various forms like fluorescence quantification or colorimetric measurements. Typically, the 
following steps can describe the HTS process applied to drug discovery: 
Primary 
screen
Compounds 
library
Biological 
question
Hits
Secondary
screen
Hits-to-leads
Confirmed 
hits
Leads
Assay
development
Clinical trials Drug
 
Figure 1. Drug discovery process using high throughput screening.  
From a biological question, a target or a mechanism is identified and allows 
developing an assay that relates the phenomenon. A compounds library is then 
chosen to be tested on the target effect and the primary screen is performed. 
Compounds that showed activity in the primary screen are called hits. These 
molecules are further tested and validated in a secondary screen. The resulting hits 
are then studied in detail for features like structure-activity relationship, toxicity or 
pharmacokinetics. The molecules are optimized and some will become leads that 
will eventually be tested in clinical trials and become a drug candidate. 
When the read out of a high throughput screening assay is images, the process is commonly 
named high content screening (HCS). This new generation of screening method introduced in 
the mid-1990s1 is emerging and becoming a powerful tool for drug discovery as well as for 
other life science research applications. In fact, the recent technological advancements like 
automated microscopy, new fluorophores discovery or increased computational power have 
enhanced the capability for acquiring and analyzing images.2 High content screening is more 
often performed in secondary screen or hit-to-lead studies, the drug discovery step where 
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compounds that showed significant activity during previous screen are re-tested and validated. 
The workflow of a high content screen is described in Figure 2. 
Assay
Compounds 
libraryCells
Assay 
reagents
Image 
acquisition
Image 
analysis
Data 
analysis
Image processing
Image segmentation
Image 
storage
Data extraction
 
Figure 2. High content screening workflow.  
Cells and compounds are incubated together and the assay is performed using the 
appropriate reagents. The images of cell phenotypes are then acquired and stored. 
After eventual image processing, images are analyzed to extract data for segmented 
regions of interest (ROI) that reflect the response of each cell to the compound. Data 
analysis determines which compounds had significant effect by comparing their 
response to the controls. 
Compared to conventional high throughput screen, image-based screening has several 
advantages and drawbacks. One of the major advantages is that high content screening assays 
can easily be multiplexed, meaning that signals from different events can be obtained from a 
single experiment. In fact, it is common in high content assays to use several probes that 
report different information for each single cell tested. One can then for instance get a 
measure of cell viability and a response to a specific assay like protein expression level within 
the same experiment. It has been shown that multiplexing application was the second most 
relevant application for high content screens, just after signaling pathway analysis.3  
Another feature of image-based assays is that the information is gathered at the cell level 
unlike most of conventional end point read-outs that get a measure at a cell population level. 
Due to the complexity of living systems, each cell, even clonal, produces slightly to highly 
different response for a same experimental condition and thus, variability in high content 
assays tend to be higher than in assays that measure overall response of a cell population.4 
However, the observed response reflects better the variability of the biological system and 
then gives more information on how cells behave individually. Generally, high content 
screening assay are considered to produce lower rate of false-positive and false-negative than 
conventional assay.5 
Imaging gives also the possibility to perform testing at sub-cellular resolution like protein 
relocation or organelles quantification that are difficult to test by other means. 
Regarding data storage and handling, high content screening raises more difficulties than 
conventional screens. For instance, an end-point fluorescent assay typically gives one data 
(fluorescence emission) for each well but a high content assay can provide several images per 
well. In terms of computing data mass, this means that the ratio between conventional screens 
and high content screen is the range of order of 1:4000 (1 octet for single digit and about 2 
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Mo per image with a minimum of two images). Thus, high content screens easily generated a 
data mass in the Teraoctet range, implying more storage cost and also more difficulties for 
data handling. Image compression is an option to reduce data mass but it is important not to 
loose information that could compromise image analysis. 
A possibility to get a data mass similar to conventional screen is to perform image 
acquisition, analysis and segmentation at the same time and store only the value of the 
extracted features of segmentation (i.e. dye intensity or nucleus area) while discarding the 
images. Nevertheless, this method removes the possibility to re-analyze images to get other 
data or inspect images by eyes which could be interesting to confirm hits and reduce false 
positive rate. Another reason to keep images is that a more powerful or specific software can 
be released, giving more possibilities to extract data. 
Despite all advancements in microscopy automation, image-based screens are much more 
time-consuming than other screens. In fact, taking images automatically is a complex process, 
especially regarding finding the focus position. A common method to find quite precisely the 
focus point is image-based autofocus. A stack of different z-position images are acquired and 
analyzed by image processing algorithm that determine which image of the stack is the most 
in-focus. This unavoidable step of imaging considerably increases the time to take images 
because several images have to be acquired and analyzed.  
In summary, high content screening opens the way for assaying cell biology features that are 
difficult to test with other assays. The obtained data tend to be closer from the real variability 
of the biological system.  
1.2. Cell viability 
Cell viability is a key topic in the drug discovery process because the toxicity of compounds 
has to be intensely tested to be able to become a drug candidate. In fact, the earlier in the 
discovery process the compound is found to have harmful effect, the faster a go/no go 
decision can be taken and precious time and investments can be saved. More, it might be 
meaningful to get a maximum of information on the toxicity source so that promising hits can 
be well characterized. Hit-to-lead optimization could also take advantage of this information 
for following up drug candidates. 
The death of mammalian cells has been classified in three distinct modes: apoptosis, necrosis 
and autophagy-associated death. These classifications have been set thanks to the different 
morphological changes and biochemical pathways that lead to the cell death. Programmed 
cell death is the process by which a cell that receives endogenous or exogenous signal, 
triggers a genetically control pathway that will lead to its death. Apoptosis is the most known 
programmed cell death although autophagy-associated is also genetically predetermined. It 
has been shown that the cell death pathways are linked and some signaling molecules have 
been proposed as molecular switches between the different modes induced cell death.6,7,8  
1.2.1. Apoptosis 
The term apoptosis has been introduced for the first time in 1842 by Carl Vogt, a German 
scientist emigrated in Switzerland, while he was working in Neuchâtel on the development of 
tadpole (aquatic larval stage of amphibian).9 Since then, apoptosis has been highly studied 
especially in the 1990th for its importance in cancer, tissue renewal and many other relevant 
biological fields. 
Two major pathways can initiate apoptosis: the death receptor pathway and the mitochondrial 
pathway. The death receptors are trans-membrane proteins that have affinity for death 
inducing signaling molecules such as members of tumor necrosis factor family. When bound 
to a ligand, these receptors initiate cell death by formation of a multi-protein death-inducing 
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complex that will activate caspase 8, central proteolytic mediator of apoptosis. The balance 
between pro- and anti-apoptotic members of the Bcl-2 protein family regulates mitochondrial 
activation of apoptosis.10 In fact, some proteins of this family (BAX and BAK) tend to initiate 
apoptosis by increasing permeability of mitochondrial membranes and inducing the release of 
cytochrome c while other like Bcl2 or Bcl-XL do exactly the opposite. If the balance tips in 
pro-apoptotic agents favor, the apoptotic process is initiated and the release of cytochrome c 
leads to the formation of apoptosomes that activate caspase 9. This pathway is typically 
activated when concentration of intracellular reactive oxygen species increases, DNA is 
damaged or the cell is deprived of growth factors. 
 
Figure 3. Pathway of apoptosis activation.  
This figure extracted from Cell Death by Hotchkiss et al.10 describes the two 
different pathways of activation of apoptosis. 
Caspases are cysteine proteases and are central mediators and effectors of apoptosis. The 
activation of caspase 8 (death receptor) or caspase 9 (mitochondria) mobilize the caspases 3, 
6, and 7 that will start to cleave lots of different proteins in the cell and also activate DNases. 
The activation of caspases causes the specific morphological changes observed in apoptosis11 
by breaking down the cellular matrix and cytoskeleton proteins. 
Morphological 
changes
Biochemical 
changes
Nuclear compaction
Activation of 
caspases and p53
Nuclear 
fragmentation
Loss of mitochondrial 
membrane potential
Cell shrinkage
Mitochondrial 
membrane 
permeabilization
Plasma membrane 
blebbing
Phosphatidylserine 
exposure
Reduction of cellular 
and nuclear volume  
Table 1. Morphological and biochemical changes due to apoptosis. 
This non-exhaustive list shows some of the changes that can be observed during 
apoptosis. 
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Other biochemical changes occur during apoptosis like translocation of phosphatidylserine. In 
viable cells, membrane proteins called flippases constantly maintain plasmic membrane 
asymmetry by inverting phosphatidylserine to the cytoplasmic side of the cell. When the cell 
enters the execution phase of apoptosis, phosphatidylserine is no more translocated to the 
inner side of cell, resulting in exposure of phosphatidylserine to the outer surface of the cell. 
This exposure is a signal for macrophages and phagocytes that will eliminate the dying cell.12 
This event appends after the activation of the caspases but before the breakdown of the 
plasmic membrane, which integrity is kept until late stage of apoptosis. 
1.2.2. Autophagy-associated death 
Autophagy (from Greek “phagy”: to eat, “auto”: oneself) is a process by which the cell 
generates energy and metabolites by digesting its own components. This state is triggered by 
a lack of nutrients and aims to make the cell survive.10 It is reversible until a certain point if 
the cell receives nutrients but if it’s not the case, the cell digests itself to death. 
Autophagy happens in four sequential steps: induction, autophagosome formation, 
degradation and reuse.13 The induction of autophagy is typically due to lack of an essential 
type of nutrient. In yeast, nitrogen, carbon or single amino acid starvation has been shown to 
induce autophagy.14 In mammals, the autophagic process is thought to be highly regulated 
because nutrients consumption and repartition is an important issue for an entire organism. 
The depletion of all amino acids and some individual amino acid starvation induces 
autophagy.15 During autophagosome formation, cell constituents such as cytoplasm 
components or organelles are randomly sequestered in a double-layer membrane from a not 
well-known origin. The resulting engulfing organelle is called autophagosome. The 
compositions of the inner and outer membrane of the autophagosome are different. In 
mammalian cells, only one component has been identified in the inner membrane.13 This 
homolog of yeast Atg8 is called LC3 and is present in three isoforms all bounded to 
autophagosome membrane but that show distinct sub-cellular localization patterns in 
autophagic cell (LC3A, LC3B and LC3C).16 Other genes, called ATG (AuTophaGy-related) 
have been identified to be involved in the regulation and execution of autophagy.17 The next 
step of the autophagic process is the degradation of the material enclosed in the 
autophagosome by lysosomal or vacuolar hydrolases. Finally, the obtained monomeric 
nutrients (amino acids, saccharides, etc) are released from the autophagosome after the 
breakdown of its membrane and reused for cell metabolism. 
Morphological 
changes
Biochemical 
changes
Vacuolization of 
cytoplasm
LC3 localization in 
autophagosomes 
membrane
Loss of organelles
ATG complex 
signaling formation
Formation of 
autophagosomes  
Table 2. Morphological and biochemical changes due to autophagy. 
This non-exhaustive list shows some of the changes that can be observed during 
autophagy. 
1.2.3. Necrosis 
Necrosis is described as the default pathway of death. A necrotic event is recorded when the 
cell is not in apoptosis or autophagy. However, necrosis shows specific morphological and 
biochemical changes. Although this type of death is not genetically programmed, some 
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modulators have been observed in the course of the events in necrosis. The sequence starts 
with mitochondrial swelling and release of reactive oxygen species in the cytoplasm. The 
increase of intracellular Ca2+ ions activates some proteases like calpain or cathepsin that 
digest key proteins of the cell. Rupture of lysosomal membrane releases other proteases and 
leads to cell demolition and plasma membrane rupture.18 Compared to apoptosis and 
autophagy, cell membrane integrity is rapidly lost in necrosis. Some morphological and 
biochemical changes are listed in Table 3. 
Morphological 
changes
Biochemical 
changes
Cytoplasmic swelling
Calpain and 
cathepsin activation
Rapid plasma 
membrane rupture
ATP depletion
Cytoplasmic 
organelles swelling
Intracellular Ca2+ 
increase
Moderate chromatin 
condensation  
Table 3. Morphological and biochemical changes due to necrosis. 
This non-exhaustive list shows some of the changes that can be observed during 
necrosis. 
1.3. Fluorescent probes 
Fluorescence spectroscopy is a powerful approach to assess living cell mechanisms by using 
appropriate fluorescent molecules. These probes consist of a molecule that identifies 
specifically a target in a cell or a complex organism and reports about activity, location or 
concentration by fluorescence emission monitoring. The read-out can be done by 
spectrofluorometry or microscopy, which offers more possibilities as described in Chapter 
1.1. The major characteristics of a fluorescent probe are: delivery, targeting, detectability and 
fluorescence response.19 Delivery is the way by which the probe reaches the target e.g. a 
protein, ion or organelle. Generally, probes are designed to be lipophilic so they cross 
membranes and can have access to cytoplasmic components or intra-organelle targets. It is 
also possible to add a low concentration of detergent that will permeabilize the membrane and 
allow the probe to enter the cell. Targeting reflects the specificity of the probe for the target. 
To design fluorescent probes, a fluorescent tag (fluorescein, GFP) can be added to a molecule 
known to have interactions with the desired target. Specificity has to be well characterized so 
the observed response is consistent with the studied phenomenon. Detectability is related to 
the fluorescent attributes of the probes such as quantum yield, extinction coefficient or 
excitation/emission wavelengths. It includes all parameters that influence the way a probe can 
be detected with the instrumentation. Fluorescence response characterizes the interaction of 
the probes with the physiological environment. Mechanisms like FRET, quenching, pH 
sensitivity or fluorescence shift has to be studied as they can interfere with the response one 
wants to observe using the probe. 
Fluorescent probes are intensively used in high content screening. A lot of applications and 
assay kits have been developed and this area is constantly growing. Below, some fluorescent 
dyes are described in particular these to assess cell viability. 
 
 
 
  
  7     
1.3.1. Hoechst and DAPI 
4',6-diamidino-2-phenylindole (DAPI) and 
Hoechst are nucleic acid stains. They 
principally bind to minor groove of DNA 
in AT-rich region and are excited by 
ultraviolet light with a maximum of 
absorbance around 350 nm.20 They re-emit 
a cyan/blue light with an emission peak at 
461 nm that is about 20-fold more intense 
than their natural fluorescence. 
Both dyes can cross the cell membranes 
but Hoechst is more lipophilic thanks to an 
additional ethyl group and thus pass 
through the membrane more efficiently. 
These dyes are used to stain the nucleus of 
cells and can information such as cell 
number, nuclear shape or cell localization. 
 
 
 
 
1.3.2. Calcein AM 
Calcein is a derivative of fluorescein broadly 
used to determine cell viability. In fact, the 
acetoxymethyl ester form (calcein AM) is non-
fluorescent and crosses the cell’s membrane 
passively. Once it has entered the cell, cytosolic 
esterases activity removes the ester group and the 
fluorescent calcein is retained within the cell. If 
cell’s membrane is not intact, calcein is diluted in 
the medium and the cytosol of the cell is not 
fluorescent.21 It has been shown that calcein is 
excluded by multidrug resistance protein (ABC 
transporter) and thus cannot be used for cells that 
express such transporters.22  
Calcein has also been described as mitochondrial 
membrane potential reporter when used with 
cobalt ions that quenches its cytoplasmic 
fluorescence.23 In summary, cells that are positive for calcein staining are considered as viable 
thanks to their esterase activity and plasmic membrane integrity. 
 
Hoechst
Chemical 
structure
Chemical 
structure
Spectra
Max. absorption
Max. emission
DAPI
358 nm
461 nm
Calcein AM
Chemical 
structure
Spectra
Max. absorption
Max. emission
495 nm
515 nm
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1.3.3. Ethidium homodimer-1 
Ethidium homodimer-1 (EthD-1) is a dye that 
has high affinity for nucleic acids. As it has 
low membrane permeability, it doesn’t enter 
cell with intact membranes. Thus, only 
nucleus of cells with damaged membrane is 
stained with EthD-1 and these cells are 
considered as dead or dying cells. EthD-1 has 
40-fold red emission fluorescence (max. at 
617 nm) when bound to nucleic acids and its 
spectra does not overlap with green-
fluorescent esterase probes as calcein AM. 
EthD-1 is similar to propidium iodide but 
superior to ethidium bromide thanks to a 
binding strength to nucleic acid around 1000 
times higher. This high affinity and enhanced fluorescence allow to use EthD-1 at a small 
concentration compared to ethidium bromide and doesn’t need a wash step due to low 
background fluorescence.  
1.3.4. FLICA 
FLuorescent Inhibitors of CAspases (FLICA) 
have been developed to test for apoptosis. As 
detailed in Chapter 1.2.1, caspases are effector 
proteases involved in apoptosis pathway. 
FLICA are composed of three parts: a 
fluoromethyl ketone (FMK) group, a short 
peptide sequence and a carboxyfluorescein 
(FAM) group and this molecule is membrane 
permeable. The FLICA inhibit caspases 
thanks to the covalent binding of FMK to a 
cysteine in the caspases reaction site. This 
interaction is possible because the short 
peptide sequence is specific to a caspase and 
several of them have been found to be 
recognized by different caspases. For 
instance, the amino acid sequence Asp-Glu-Val-Asp (DEVD) is specific for caspase 3 and 7 
while Leu-Glu-Thr-Asp (LETD) has affinity for caspase 8. The FAM group is the fluorescent 
reporter that allows the molecule to be detected by fluorescence imaging. Thus, cells that have 
enough activated caspases should be stained by FLICA showing their apoptotic state. 
 
Ethidium homodimer-1
Chemical 
structure
Spectra
Max. absorption
Max. emission
528 nm
617 nm
FLICA
Chemical 
structure
Spectra
(Carboxyfluores
cein)
Max. absorption
Max. emission
FAM-Asp-Glu-Val-Asp-FMK
Carboxyfluorescein-peptide sequence-fluoromethyl 
ketone
488 nm
530 nm
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1.3.5. Annexin V conjugate 
Annexin V was first isolated from a fraction 
of human umbilical cord artery in 1985 
reported by Reutelingsperger et al.24 for its 
anticoagulant properties. The protein was then 
expressed in bacteria thanks to cDNA cloning 
and was found to have numerous activities 
such as anticoagulant, anti-phospholipase or 
trans-membrane channel activity.25 However, 
the phospholipid binding property of annexin 
V is the most known. In fact, annexin V binds 
to phosphatidylserine (PS) in presence of Ca2+ 
and can therefore be used to detect apoptosis. 
As explain in Chapter 1.2.1, phosphat-
idylserine is translocated to the outer surface 
of the cell during apoptosis and acts as an 
elimination signal for macrophages and 
phagocytes. To detect apoptosis, annexin V is 
conjugated to a fluorophore (e.g. Alexa 
Fluor 488) and added with Ca2+ in the supernatant of the cells to be tested. As this probe is 
not membrane permeable, external side of the membrane of cells that have exposed PS is 
stained, enlightening their apoptotic state. However if cell membrane is broken meaning that 
the cell is in late state apoptosis or necrosis, annexin V enters the cell and binds to 
cytoplasmic-oriented PS. This implies that annexin V probe should be used with proper 
counter-stain like propidium iodide or EthD-1 that enters only membrane-damaged cells and 
permits to discriminate between apoptotic and late apoptotic/necrotic cells. In summary, 
annexin V combined with nuclear and dead cell counter-stain allows to distinguish three 
populations of cells: viable cells (stained only with nuclear probe), early apoptotic cells 
(stained with nuclear and annexin V probes) and late state apoptotic/necrotic cells (stained 
with nuclear, annexin V probes and dead cell counter-stain). 
1.3.6. LC3B antibody 
In Chapter 1.2.2, LC3B has been described to be linked to the membrane of autophagosomes, 
the effectors organelles of autophagy. Antibody against LC3B can thus be used to detect 
autophagy using immunostaining procedure. Autophagosomes are located in the cytoplasm of 
autophagic cells and as antibodies cannot cross cell membrane, the use of a detergent that will 
permeabilize the membrane is unavoidable. The primary antibody has specific affinity for 
LC3B protein can then enters the cell and binds to this protein on the membrane of 
autophagosomes. A secondary antibody against antibody of the species in which the primary 
antibody has been produced, will bound to the primary antibody. This secondary antibody is 
conjugated with a fluorophore that can be detected by fluorescence microscopy. Cells that are 
in autophagic state should show small bright dots in their cytoplasm, representing the 
autophagosomes.   
 
 
Annexin V conjugate
Protein structure
Spectra
(Alexa 488)
Max. absorption
Max. emission
488 nm
530 nm
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1.4. Assay development 
The aim of assay development in HTS cell-based assay is to set up a measurable and reliable 
reporter of a biological activity. The reporter, or probe, interacts with a target mechanism that 
reflects the cellular activity to be evaluated and the emitted signal quantitatively defines the 
activity of a cell or a cell population. Once a reporter is found to significantly give a 
difference in signal between relevant phenotypes of cells, the assay has to be intensively 
optimized to reach the high-throughput screening requirements.  
In HCS, probes are most of the time fluorescent molecules that can bind to a target cellular 
component or be modified by cellular metabolism resulting in a change of their fluorescence 
properties. Probes should accurately reflect the underlying biology and minimize artifacts 
thanks to high specificity for the target mechanism. For HCS assays, the two most important 
parameters to be optimized are: high signal-to-background ratio and low variability.26 Every 
step of the assay has to be adjusted so that the background signal is as weak as possible 
compared to the measured signal. This ratio is influenced by several factors like the probe and 
its fluorescence properties, the staining or fixation protocols, the liquid handling or the 
number of cells seeded per well. Each of the variation of these parameters has to be evaluated 
with image analysis solution in order to define their influence on assay read-out. The assay 
has to be highly reproducible and controls should carefully be chosen and analyzed as they 
have strong influence on the meaning of the assay. They should reliably correspond to the 
phenotype of the biological activity to be tested so that obtained results are consistent with the 
biological question. 
The choice of the probe has high consequences on the assay feasibility and quality. In fact, 
this choice mainly determines the protocol, the image analysis algorithm and also the cost of 
the resulting process. For instance, probes that imply long staining protocol or require 
computationally expensive image analysis solution will considerably lengthen the process and 
increase total cost of screen. Consequently, the whole HCS process has to be considered when 
an assay is set up and optimized. 
Quality of assays are commonly estimated with z’ factor27. This dimensionless statistical 
parameter represents the separation of the signal between the positive and negative 
populations and its definition is shown in Equation 1.  
  
€ 
z'=1− 3(SD+ + SD−)
µ+ − µ−
, 
€ 
1≤ z'< −∞  
  where,  µ+ and SD+ the mean and the standard deviation of the positive  
   control, µ- and SD- the mean and the standard deviation of the  
negative control 
Equation 1. z’ factor definition. 
The z’ factor quantitatively estimates the robustness of an assay by characterizing the 
screening window that could be used to identify hits. Positive z’ values (with a maximum 
of 1) indicate that separation is possible between positive and negative populations unlike 
negative z’ values, where these populations are merged. In HCS assay, every cell is analyzed 
and due almost infinite phenotype possibilities, outlier values commonly appear. Also, 
positive cell phenotype could append in negative control and vice-versa. These outliers 
usually have strong influence on the mean and the standard deviation and could dramatically 
lower z’ factor. 
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1.5. High content-image analysis 
High content screening produces images. If human eyes and brain can easily identify objects 
within an image, computerize this ability is a challenge. In order to get numerical data and be 
mathematically able to compare different cell phenotypes, images have to be analyzed. The 
automated image analysis process in HCS is called high content analysis (HCA).  High 
content-image analysis aims to quantify the response of an assay by interpreting images and 
extracting data from those. The development of HCA has made possible high content 
screening, as this one is meaningful only if data can be obtained from the produced images. 
HCA is based on mathematical operations with picture elements (pixels); a particular HCA 
process is thus invariant and fully reproducible. Image analysis can be divided in three parts: 
image correction, image segmentation and feature extraction.28 
Image analysis process typically starts with image corrections that aim to enhance image 
quality and create a more pronounced distinction between background signal and objects. 
Compensation of uneven illumination of the sample during image acquisition is a common 
step to improve image quality. In fact, imperfections of the optical system (e.g. slight 
component misalignment, dust) could create non-uniform illumination of the sample and thus 
differences in signal in the image only due to unequal excitation of the fluorophore. Flat field 
correction is used to compensate this effect and consists of correcting images with a reference 
image containing no sample. The reference image depends on the different optical 
components such objectives or laser lamps. An illustration of flat field correction is shown in 
Figure 4. !
+ 
 
Figure 4. Flat field correction. 
For each pixel of the acquired image, the flat field corrected corresponding pixel Icorr is 
defined as described in Equation 2. 
  
€ 
Icorr =
Iori
Iref
⋅ mref  
  where, Iori the intensity of the pixel in the original image, Iref the 
corresponding pixel value in the reference image and mref the  
median of the reference image 
Equation 2. Calculation of the flat field correction. 
Constant value background subtraction can be used to minimize background signal. However, 
this method can alter the signal by flattening informative pixels and therefore has to be 
avoided as possible. Smoothing filters can be applied to reduce noise induced by acquisition 
system but they have to be carefully parameterized so they do not blur edges of objects or 
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remove small area informative objects. As a general rule, raw images must always be stored 
in case some processes altered the information contained in the images. 
The main part of image analysis is image segmentation in which objects are segregated from 
the background signal. The simplest method to distinguish objects from background is to set 
an intensity threshold that highlights only pixels with high intensities, which should represent 
objects. Adjacent pixels above the defined threshold are then considered to be part of the 
same objects. In fact, intensity histogram of image obtained with fluorescent cell-based assay 
should ideally contain two separated peaks, the background signal and objects signal. This 
method works well only with several assumptions that are: image is not overcrowded with 
objects and most objects are spatially separated, image illumination is flat (or efficiently 
corrected) and objects signal is separated from background signal. Image processing filters 
can be used to enhance general contrast of the image or put in evidence some shapes that have 
to be segmented. Edge detector or sharpen filters could be useful to detect objects and 
increase intensity separation with adjacent elements, making thresholding easier. Segmented 
objects or shapes are often called region of interest (ROI). Once objects are segmented and 
their contours are spatially defined, their area can be calculated and thresholds can be set to 
remove small and large objects that could be noise or aggregates of the target shape. 
Watershed is a popular algorithm used to separate objects and the idea behind this algorithm 
is based on topography. Local maxima (objects) and minima (background) are considered 
respectively as hills and valleys and this imaginary landscape is filled with water. As level of 
water increases, valleys are flooded and the hills that stay out of water at a certain level are 
defined as objects.29 This iterative algorithm has to be moderately used, as needed 
computational resource can rapidly increase like for other segmentation methods. For 
instance, segmentation based on edge tracing algorithm or using morphological templates 
fitted on the image are computationally expensive and might be not appropriate for HCA. A 
combination of simple thresholding and light version of these algorithms is often used to 
improve segmentation. 
Unlike human eyes that are only sensitive to relative intensity values, computers can easily 
determine absolute intensity of regions within an image. This ability is used to extract 
different features of the segmented objects. Intensity (e.g. mean, median, standard deviation), 
shape (e.g. area, perimeter), surface (e.g. granularity, texture) and distribution (e.g. mean 
distance between objects) features can be calculated in the ROI obtained by segmentation. 
These values are used to characterize the phenotypes encountered in each image and have to 
be relevant to the biology behind. Most of the time, the more features are extracted, the more 
precise the classification is. However with hundreds of objects in image and hundreds to 
thousands images in a screen, the volume of data generated by these features can be huge and 
has to be monitored.  
HCA is a difficult and crucial part of the HCS process and can be a bottleneck to this type of 
screening. To keep high throughput, image quality is often lowered and harden image 
analysis. A generic solution for all image analysis is not conceivable as every segmentation 
problem is different. Errors of segmentation have to be considered in data analysis and 
compensated by statistically significant number of observations. The HCA process has to be 
evaluated in time and computational resources as they have high repercussions on the quality 
and the cost of a screen.  
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2. Materials and methods 
2.1. Cell culture 
Henrietta Lacks (HeLa) cells were maintained in adherent flask culture during the whole 
length of the project. The cells were originally purchased at American Type Culture 
Collection (HeLa CCL-2) and grown at 37°C in humidified incubator containing 5% CO2. 
The medium used was Dulbecco's Modified Eagle Medium + GlutaMAX (Invitrogen, 
Carlsbad, CA, ref. 32430) supplemented with 10% heat inactivated fetal bovine serum 
(origin: Australia, Invitrogen, Carlsbad, CA, ref. 10101-145).  
Typical passage rate was twice a week with a dilution of 1:10 in 75 cm2 flasks (Techno 
Plastic Products, Trasadingen, Switzerland, ref. 90076). Passaging was done by removing old 
medium, washing cells with phosphate buffer saline pH 7.4 (Invitrogen, Carlsbad, CA, ref. 
10010) and detaching the cells with trypsin-EDTA (Invitrogen, Carlsbad, CA, ref. 25300) for 
around 10 min at 37°C. One milliliter of cell solution was then usually diluted in 9 ml of fresh 
medium heated at 37°C. Cell concentration was determined in the rest of the solution by 
counting in hemocytometer and cells were plated at a defined concentration to perform 
experiments. Different passage rates and dilutions were used to get enough cells for some 
experiments. When the number of passage was about 50, a new vial of lower passage number 
cells was thawed and re-cultured as described above. 
2.2. Cell death inducers 
Toxic molecules were used to induce cell death in HeLa cells. Three different protocols were 
tested to determine half lethal concentration (IC50) for an initial population of 3’000 cells per 
well added as 90 µl in 96-well plates: 
• Cell death inducer was added as 10 µl at the same time that the cells and incubated 
24h. 
• Cell death inducer was added as 10 µl 24h after the cells were plated and incubated 
48h. 
• Cell death inducer was added as 10 µl 48h after the cells were plated and incubated 
24h. 
Cell viability was then determined using alamarBlue assay by adding 10 µl of alamarBlue 
(AbD Serotec, Kidlington, UK, ref. BUF021A) and incubate 4h at 37°C. The alamarBlue is 
composed of resazurin, a permeable non-fluorescent substrate that is reduced by living cells, 
producing resorufin a red fluorescent product. Quantification of resorufin fluorescence was 
done using Safire2 (Tecan, Männedorf, Switzerland) with excitation/emission filter 
560/590 nm and can be used to determine the viability of the cell population by comparing 
fluorescence emission with appropriate controls. The positive control (dead cells) was CuSO4 
10-2 M and negative control (living cells) was chosen according to the solvent of death 
inducer (either H2O or DMSO 0.3%). These different protocols were tested to get precise and 
time-dependent IC50 so that they are consistent with the assay to perform.  
The following list shows cell death inducers tested and their reference: 
• Ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich, St. Louis, MO, ref. E5134) 
• Gambogic acid (GBA) (Tocris Bioscience, Bristol, UK, ref. 3590) 
• Sodium azide (NaN3) (Sigma-Aldrich, St. Louis, MO, ref. S2002) 
• Staurosporine (Roche, Basel, Switzerland, ref. 11055682001) 
• Terpinen-4-ol (Sigma-Aldrich, St. Louis, MO, ref. 86477) 
• Celastrol (Cayman Chemical, Ann Arbor, MI, ref. 70950) 
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2.3. Probes 
The different fluorescent probes were handled and stored as advised by the providers. The list 
below shows the used probes where the were purchased: 
• Hoechst 33342 (Invitrogen, Carlsbad, CA, ref. H1399) 
• 4',6'-diamidino-2-phénylindole (DAPI) (Sigma-Aldrich, St. Louis, MO, ref. D9542) 
• Calcein AM (Invitrogen, Carlsbad, CA, ref. C3100MP) 
• Ethidium homodimer-1 (Invitrogen, Carlsbad, CA, ref. E1169) 
• FLICA (Invitrogen, Carlsbad, CA, ref. I35106) 
• Annexin V conjugate with Alexa Fluor 488 (Invitrogen, Carlsbad, CA, ref. A13201) 
• LC3B rabbit antibody (Invitrogen, Carlsbad, CA, ref. L10382) 
• Anti-rabbit antibody labeled with Alexa Fluor 647 (Invitrogen, Carlsbad, CA, ref. 
A21244) 
These probes were tested on HeLa cells in 96-well plates and optimization was done 
according to the procedure described below.  
2.4. Staining optimization 
The aim of staining optimization is to get a maximal ratio between the signal one wants to 
observe and the background signal so that the signal for the positive and negative populations 
are separated enough for discrimination. Almost every step of the HCS process influences the 
read-out, from the number of plated cells to the segmentation parameters. The optimization 
was done by varying these different parameters that change the way a probe will be localized 
on its target and estimating how the positive and negative populations are separated. These 
parameters could be probe concentration, probe solvent, incubation time, incubation 
temperature or number of washes. For most of the probes, a starting protocol was defined by 
looking on provider documentation for the product or in the literature. From this protocol, 
parameters were slightly to broadly changed and staining quality was estimated for these 
conditions. HeLa cells in 96-well plates were used to perform these tests, typically at a 
concentration of 3’000 cells per well the day before the assay was done. The staining protocol 
are shown in Appendix 6.2. 
Fluorescent probe staining often requires one or several wash steps in order to minimize 
background fluorescence of the probe diluted in the medium. When working on adherent cell 
culture in multi-well plate, these wash steps are usually performed with liquid handlers that 
remove a certain amount of medium in each well and refill the wells with liquid to dilute the 
primary medium. A problem that could arise from these steps is the detachment of cells that 
are aspirated by the liquid handlers generating loss of data or biased population. Especially 
when cells are dead, they naturally detach from well and thus are easier aspirated. Wash 
protocol validation was done by killing the cells with 10 mM CuSO4 for 24h and staining cells 
with Hoechst. Initial concentration was estimated by acquire images of cells that have been 
homogenized by pipetting 3-4 times up and down and centrifuged for 2 min at 1000g. The 
wash step when then performed with different protocols on ELx405 Microplate Washer 
(BioTek, Winooski, VT) and Biomek® 3000 Laboratory Automation Workstation (Beckman 
Coulter, Brea, CA). Cells were homogenized and centrifuged again and imaged to estimate 
percentage of remaining cells. The wash efficiency (percentage of dilution of the initial 
medium) was measured by spectrofluorometry with 200X fluorescein, which fluorescence 
was acquired with Infinite® F500 (Tecan, Männedorf, Switzerland) before and after wash. 
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2.5. Automated microscopy 
The automated microscope used was a BD Pathway855. This fluorescence microscope 
offers a wide range of visualization spectra (340 nm to 750 nm) thanks to dual-mercury metal 
halide lamps. The light path can be set up as wide field or it is possible to take spinning disk 
images. Temperature and carbon dioxide controls inside imaging chamber allow time-lapse 
microscopy with living sample. A basic liquid handling module is present and can be used to 
add a reagent for instance when imaging should starts directly after the addition of a reagent 
for short term reactions.  
An image analysis software called Attovision is also provided. This software allows the 
controls the different part of the microscope like motorized objective, light paths or liquid 
handling module and let build macros for automation of imaging. These macros were used for 
imaging and typically started with autofocus command composed either of two image-based 
autofocus (coarse and fine) or laser-based autofocus and fine image-based autofocus. In laser-
based autofocus, the bottom position of the plate is found thanks to the change of refractive 
index between the transition air-plastic and plastic-medium. This type of autofocus is faster 
than image-based autofocus, which consists of acquiring images at different Z positions and 
use image processing algorithm (Vollath F4) to define which image is in focus thanks to 
estimation of image sharpness and contrast. The focus position was found on nuclear stain 
and the other lightpaths were acquired at this position. A montage of 2x2 or 3x3 images with 
20X objective was usually set up to get a larger sample of each well. All images were 
acquired with a 20X objective, Universal Apochromatic, NA: 0.75, xyFOV 420 x 320 µm, 
Olympus (Shinjuku, Japan, ref. UAPO20X/340) if no other mention. 
The software also provides segmentation capabilities and data analysis features. To find cell 
position and cell number, nuclear stain image was used. After flat field correction, image 
processing algorithms RB 25X25 (rolling ball) and shading (algorithms not disclosed) were 
applied to respectively reduce background and sharpen image by equalizing intensity of bright 
objects. A threshold was then set to discriminate between background and cell nuclei. This 
threshold was relative to mean intensity of each image and was automatically adapted if an 
image was brighter or darker. Watershed was used to split nuclei that were too close to be 
separated by intensity thresholding. Finally, objects with smaller or bigger area than defined 
thresholds were discarded, as they either were debris or aggregates of nuclei that were not 
split by watershed. Whole cell was defined by dilation of nine pixels from nucleus border. 
This segmentation resulted in two ROI: cell nucleus and whole cell. These ROI were used for 
measurements in the different images acquired with the lightpath corresponding to the probes. 
A two-steps segmentation was necessary to get whole cell ROI and nucleus ROI (see Figure 
5) because of limitation of the software. Exact parameters of segmentation are shown in 
Appendix 6.3. 
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Figure 5. Segmentation process. 
First step of segmentation aims to define whole cell mask. After flat field correction, 
RB 25X25 is used to remove background. Shading allows brightening objects with 
low intensity. A threshold is then set to discriminate between background (shown in 
blue) and nuclei. Dilatation of 9 pixels is used to define whole cell. The second step 
of segmentation use the same parameters without the final dilatation to define cell 
nucleus. 
2.6. Data analysis 
After image segmentation, different features were extracted depending on the assay 
performed. Parameters like mean pixels intensity within a ROI, total area or intensity 
variations in a ROI were typically measured to characterize each object found in 
segmentation. Attovision wrote output data in a text file containing each object in row and 
its parameters in the corresponding column for each well analyzed. The different wells were 
horizontally separated by several rows containing information on the used lightpath and other 
acquisition parameters. As this data configuration was not favorable to data handling and 
analysis, a Visual Basic for Applications macro was coded in Microsoft Office Excel to 
re-organize data in a way that makes easier their manipulation. Data were organized by well 
in adjacent columns and objects with their parameters in rows. The macro also removed some 
ROI automatically generated by Attovision to enhance data visibility. To get a fast 
overview of plate response map, mean value of the different parameters extracted were also 
automatically computed for each well and written in separate sheet. A second macro was 
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coded to gather all images of an experiment together in a single folder as Attovision placed 
these images in a not user-friendly arborescence of folders. Information and user guideline of 
these macros can be found in Appendix 6.4. 
The aim of data analysis was to find the threshold that defined positive and negative 
populations for cells stained with a probe. For this purpose mean signal and variation of 
positive and negative controls were computed. Relevant features extracted from segmentation 
should show distribution shift between positive and negative controls as shown in Figure 6. 
!
Value 
Frequency Normal 
distribution 
Effect of the 
compound 
 
Figure 6. Typical distribution of value in an assay. 
Normal response of a biological system to an assay compared to a positive 
distribution. Positive compounds should induce a change in mean signal of the 
parameter measured. 
For intensity measurements, negative control represented usually mean background signal of 
the image, as most of the cells should not be stained with the used dye. However, some 
positive cells might be found in negative control and in order to find a threshold that really 
corresponds to negative signal, outlier values were removed from mean and standard 
deviation computation. For a dataset [x1, x2,…, xn] sorted in ascending order, outliers were 
defined as shown in Equation 3. 
  
€ 
xi >Q3 +
3
2 (Q3 −Q1)   or 
  
€ 
xi <Q1 −
3
2 (Q3 −Q1), for  
€ 
1≤ i ≤ n , 
€ 
i ∈ , 
 where,  
  
€ 
Qp = xk + d⋅ (xk+1 − xk ),  
€ 
k = p4 (n −1) +1
⎢ 
⎣ ⎢ 
⎥ 
⎦ ⎥ 
 and 
  
€ 
d = p4 (n −1) +1− k, for  
€ 
1≤ p ≤ 3, 
€ 
p ∈ , 
Equation 3. Outliers definition. 
In other words, values that were 1.5 times the inter-quartile distance over the superior quartile 
and the same distance below the inferior quartile were removed for mean and standard 
deviation computation. Three standard deviations over and below mean exclusion could also 
have been used but this method took more in account the distribution of the data that was 
often present in staining experiment. For instance in negative control, this distribution could 
typically be represented by two Gaussians: most cells were distributed around the mean of 
negative signal and few cells that were positives created a small Gaussian-like distribution 
with a mean close to positive response. The described procedure corrected this effect most of 
the time to get a mean value and standard deviation corresponding the positive or negative 
populations. Thresholds were then set usually at three standard deviations from the corrected 
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mean to define the criterion of membership to a population. These thresholds were checked 
by going back to some images and estimating by eyes classification if the right population 
was segregated with the defined criterions. 
The relevance of a features extracted from image segmentation was estimated by computing 
z’ factor using the positive and negative controls. In fact the higher the separation between the 
positive and negative distributions was, the more certain the classification of cells in each 
populations was. 
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3. Results 
3.1. Staining results 
3.1.1. DAPI and Hoechst 
The nuclear probes Hoechst 33342 and DAPI were tested and optimized for HeLa cells in 96-
well plate. Hoechst staining was tested within a concentration range from 0.25 µg/ml to 40 
µg/ml, incubation time from 5 min to 45 min, incubation temperature 37°C/room 
temperature (RT), with 0X/1X wash with PBS and on living/dead cells.  
The probes showed homogeneous nuclear signal after 15 min at 37°C and about 30 min at 
RT. With lower incubation times, the nuclei of cells were stained only on their border 
showing that the diffusion and fixation process of the probe was not advanced enough. The 
signal within cell nucleus was about 5-8 times higher than the background signal with 
Hoechst concentration above 1 µg/ml, giving wide possibility of thresholding to distinguish 
nuclei from background. Each of the cited conditions above with this concentration range 
gave the possibility to efficiently segment cell nuclei from background signal, the main 
purpose of nuclear staining. When the concentration was below 1 µg/ml, segmentation was 
less efficient because cell nuclei intensity was about 1.5 to 3 times higher than background. 
For these concentrations, exposition time was increase from around 0.008 s to 0.03 s so that 
the signal was detectable by the CCD camera. The wash step showed no significant 
improvement of signal-to-background ratio. Cytoplasm intensity was comparable to 
background signal proving high specificity of Hoechst to DNA.  
To minimize acquisition time and quantity of used probe, the final optimal concentration 
further used for this project was set at 1 µg/ml. The optimal parameters are summarized 
in Table 4. 
Hoechst staining
Parameter Value
Final 
concentration
Incubation time
Incubation 
temperature
# of wash 
required
Approximative 
exposure time
1 μg / ml in H2O
15 min 30 min
37°C RT
0X
0.008 s
 
Table 4. Hoechst staining parameters. 
 
Similar optimization was done for DAPI staining. As shown in Figure 7, it appeared that 
background signal was more intense than in Hoechst staining with a ratio of about 1.2 
between cell nuclei and background even with flat field correction. The wash step with 100 µl 
PBS per well significantly improved this ratio by increasing it between 4-6, a similar result to 
Hoechst staining. This phenomenon might be due to lower lipophilicity of DAPI compared to 
Hoechst as explained in Chapter 1.3.1.  
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Figure 7. Need for a wash step in DAPI staining. 
The left side of the figure shows HeLa cells stained with 10 µg/ml DAPI after 20 
min incubation at 37°C. On the right side, the same cells after one wash with 100 µl 
of PBS. 
The incubation time and temperature were similar to Hoechst and optimal concentration was 
10 µg/ml. These parameters are shown in Table 5. 
DAPI staining
Parameter Value
Final 
concentration
Incubation time
Incubation 
temperature
# of wash 
required
Approximative 
exposure time
10 μg / ml in H2O
15 min 30 min
37°C RT
1X
0.01 s  
Table 5. DAPI staining parameters. 
 
Except from cell number and position, another feature that could be extracted from nuclear 
stain was nucleus shape. In fact as shown in Figure 8, the nucleus of cells has a different 
morphology when the cell is viable, apoptotic or necrotic. Cell nucleus also adopts distinct 
morphology during the mitotic process and depends on cell cycle. Viable cells showed 
uniform nuclear stain with almost regular oval shape. For necrotic cell nucleus, the staining 
intensity was higher than in viable cells and nuclear area was reduced. Characteristic nuclear 
fragmentation was observed in apoptotic cells, as their nucleus contained small bright dots. 
This information that can be used to get insights of cell state is further depicted in 
Chapter 3.2.2. 
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Figure 8. Hoechst staining showing nuclear morphology of viable, necrotic and 
apoptotic cells. 
HeLa cells stained with Hoechst 1 µg/ml. A. Viable cells. B. Cells treated with 
10 mM CuSO4 for 24h at 37°C (necrotic cells). C. Cells treated with 10 µM 
staurosporine for 4h at 37°C (apoptotic cells). 
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3.1.2. Calcein and EthD-1 
Calcein staining was optimized for HeLa cells in 96-well plate. The parameters tested were: 
concentration range [0.0625 – 4 µg/ml], solvent PBS/water, incubation temperature 37°C/RT 
and incubation time from 20 to 60 min. Hoechst 33342 staining was first chosen as nuclear 
probe to identify cell number and position as it seemed more efficient than DAPI. 
Nevertheless, it appeared that when Hoechst was used with calcein, the repartition of calcein 
within cell cytoplasm was not homogeneous and aggregates were presents in medium. As 
shown in Figure 9, DAPI had not this effect on calcein and was thus chosen as nuclear stain 
for calcein assays.  
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Figure 9. Calcein-AM staining is degraded by Hoechst but not by DAPI. 
HeLa cells stained with A. 10 µg/ml DAPI (cyan) and 0.5 µg/ml calcein-AM 
(green). B. 1 µg/ml Hoechst (cyan) and 0.5 µg/ml calcein-AM (green). The upper 
and lower corresponding images are extracted from the same plate and thus have the 
same experimental conditions. The two left images are acquired with a 40X 
objective. 
The lower concentration of calcein that allowed decent segmentation was 0.5 µg/ml and no 
significant differences was observed when the solvent was PBS or H2O. Incubation time was 
found to be minimum 30 min at 37°C and 45 min at RT so that esterase activity was 
detectable. Residual fluorescent calcein was present in dead cells and was partly removed by 
one wash with 100 µl of PBS. The wash step also diminished the background signal due to 
the esterase activity of FBS present in medium. The parameters are summarized in Table 6. 
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Calcein staining
Parameter Value
Final 
concentration
Incubation time
Incubation 
temperature
# of wash 
required
Approximative 
exposure time
Notes
0.5 μg / ml in H2O
30 min 45 min
37°C RT
1X
0.01 s
Do not use with Hoechst 33342  
Table 6. Calcein staining parameters. 
The nucleic acid probe EthD-1 was tested on HeLa cells in 96-well plate with concentrations 
between 0.125 µM and 12 µM. The best concentration found was 1 µM with incubation time 
of 30 min at 37°C and 50 min at RT. Cell death was first induced by treatment with 70% 
ethanol at – 20°C for 15 min to get rapid death and so that cells stayed attached. As shown in 
Figure 10, the phenotype of cells killed by this way does not correspond to most of dead cell 
shape. In fact, cytoplasm of cells looked intact as they were fixed whereas “natural” dead 
cells adopted round shape. Thus, the control was changed to 10 mM CuSO4 incubated 24h. !"#$%&#'#$%&()#*+,-#./#012#3"#4%5678#.,*/#.,&#
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Figure 10. EthD-1/Hoechst dual staining of cells treated with – 20°C EthOH and 
staurosporine. 
HeLa cells stained with 1 µM EthD-1 (red) and 1 µg/ml Hoechst (blue). A. Left: red 
channel of cells treat with 70% EthOH at – 20°C for 15 min. Right: same image 
merged with blue channel. B. Left: Red channel of cells treated with 10 µM 
staurosporine for 10h. Right: same image merged with blue channel. 
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Another phenomenon that could appear is competition between nuclear probe and EthD-1 as 
both of them bind to DNA. Comparison of the addition of EthD-1 10 min before Hoechst with 
further incubation of 20 min at 37°C and both dyes added together incubated 30 min at 37°C 
was done to control this effect. EthD-1 staining showed no significant difference between the 
two protocols performed on the same plate. Staining parameters with EthD-1 are shown in 
Table 7. 
EthD-1 staining
Parameter Value
Final 
concentration
Incubation time
Incubation 
temperature
# of wash 
required
Approximative 
exposure time
1 μM in H2O
30 min 50 min
37°C RT
0X
0.03 s
 
Table 7. Ethidium homodimer-1 staining parameters. 
The combination of the three probes (calcein-AM, EthD-1 and DAPI) was tested at the 
defined concentrations with incubation time of 30 min at 37°C. This assay use intracellular 
esterase activity and membrane permeability to discriminate between living and dead cells 
and best images of this test are shown in Figure 11. 
A B 
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Figure 11. Live/dead assay with calcein-AM, EthD-1 and DAPI. 
The figure shows HeLa cells stained with 0.5 µg/ml calcein (green), 1 µM EthD-1 
(red) and 10 µg/ml DAPI (blue). A. Viable cells. B. Cells treated with 10-2 M CuSO4 
for 24h at 37°C (dead cells). 
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3.1.3. FLICA 
The apoptotic indicator based on caspases activation FLICA was tested on HeLa cells in 96-
well plate. The probe was combined with Hoechst to detect cell number/position and 
propidium iodide that stains late apoptotic/necrotic cells due to their damaged membrane. 
Kinases inhibitor staurosporine was used to induce apoptosis at a concentration of 10-4 M, 10-
5 M, 10-6 M and 10-7 M. After 2h and 4h incubation with staurosporine, most of the cells were 
negative for FLICA staining and the signal for positive cells was low (see Figure 12A). Even 
with up to three wash steps, the background signal was high and to ratio with positive cells 
was about 1.2, which was not sufficient for efficient discrimination between apoptotic and 
living cells. Another test was performed with 6h incubation with staurosporine at the cited 
concentrations and the best images were most of the cells were positive for FLICA are shown 
in Figure 12B. The ratio between positive cells and background was increased to about 1.8 
and the separation between positive and negative cells stayed difficult. !"#$%&'!#()*+,-#./##0"#$%&'!#()*+,-#1/# A 
B 
A 
 
Figure 12. FLICA staining. 
HeLa cells stained with FLICA. A. After 2h incubation with 10-5 M staurosporine. 
B. After 6h incubation with left: 10-4 M staurosporine and right: 10-5 M 
staurosporine. 
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3.1.4. Annexin V conjugate 
Annexin V conjugate, a probe that binds to phosphatidylserine, was tested to detect apoptosis 
on HeLa cells in 96-well plate. Positive control was done by treatment with staurosporine, a 
kinase inhibitor known to induce apoptosis, at different concentration (10-4 M, 10-5 M and 10-
6 M). The probe was combined with Hoechst and EthD-1 to detect cell with compromised 
plasma membrane (see Chapter 1.3.5). Tests were performed after 3h, 4h, 8h and 24h 
incubation with staurosporine and a time-lapse analysis was done by acquiring images every 8 
min for 10 hours. The first experiment was done with 3h and 24h incubation of 10-4 M, 10-5 
M and 10-6 M staurosporine. At 10-6 M, no apoptotic cells were detected after 3h and few 
dead cells (annexin V and EthD-1 positives) were present after 24h. This concentration was 
not high enough to induce apoptosis. At 10-5 M, nuclear fragmentation was observable in 
most of the cells and some were positives for annexin V staining after 3h. With the same 
concentration and 24h incubation, half of the cells were EthD-1 positive and a third of the 
population was positive for annexin V. When the concentration of staurosporine was 
increased to 10-4 M, half of the cells showed phosphatidylserine translocation after 3h and 
nuclear fragmentation was present in all cells. After 24h incubation at this concentration, most 
of the cells were dead with few of them still in apoptotic process. Thus, the concentration of 
10-5 M was defined as reference for its similar time to induce apoptosis compared to what was 
found in literature. With higher concentrations, compounds that would trigger apoptosis in a 
longer period would be missed. An other test was performed with this concentration and an 
incubation time of 4h and 8h. With 4h incubation, a small half of the population was engaged 
in the apoptotic process. After 8h, almost all of the cells were positive for annexin V staining 
and negative for EthD-1 showing that the time of incubation was in the right order of 
magnitude. 
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Figure 13. Annexin V conjugate staining. 
HeLa cells stained with 50X annexin V conjugate (green), 1 µg/ml Hoechst (blue) 
and 1 µM EthD-1 (red) A. Cells treated with 10 µM staurosporine. B. Negative 
control. 
Time-lapse analysis was performed to get insight of the timeframe in which 
phosphatidylserine translocation appends and cell membrane is still intact (Figure 14). Two 
conditions were tested: control and cells treated with 10-5 M staurosporine. After 3h30, the 
majority of cells treated with staurosporine were stained with annexin V conjugate and not 
with EthD-1. Cell membrane became permeable for most cells in these wells after around 6h. 
This timeframe was shorter than what was observed by end-point experiments. However, this 
time could be influenced by several apoptotic-inducing factors that are: presence of Hoechst 
33342 and fluorescence imaging. Apoptosis induction by these factors was confirmed in 
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control wells that showed phosphatidylserine translocation in most cells after 5h and about 
half of the cells were positive for EthD-1 after 10h. Imaging capability to induce apoptosis 
was further confirmed as first apoptotic cells appeared at the center of the image, where auto-
focus images were taken. Thus, these cells that received more irradiation by laser engaged 
apoptosis pathway before surrounding cells. This proves that the apoptosis induction and 
mechanism of phosphatidylserine translocation are time-dependent and their execution 
depends on the nature and the amount of inductors. !"#$%&'()$%*++$,"+%-./%0%12$34)5%678%%$54%678%*9 5:.%;9 5:<4%=9 5:6.4%%%%%%
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Figure 14. Time lapse analysis of annexin V conjugate staining. 
Cells were stained with 1 µg/ml Hoechst (blue) for 15 min at 37°C. After 1X wash 
with 100 µl PBS, a solution of annexin-binging buffer (10 mM HEPES, 140 mM 
NaCl, 2.5 mM CaCl2) containing 50X annexin V conjugate (green), 1 µM EthD-1 
(red) and 10 µM staurosporine was added. Images of Hoechst (blue), annexin V 
conjugate (green) and EthD-1 (red) channels were taken every 8 min for 10h in 
chamber kept at 37°C and 5% CO2. A. Time t=0. B. t=4h. C. t=10h. 
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3.1.5. LC3B antibody 
LC3B immunostaining was tested to detect autophagosomes formation in HeLa cells in 96-
well plate. Different concentrations of primary antibody (0.5 µg/ml, 1 µg/ml), secondary 
antibody (200X, 500X, 1000X, 2000X) and blocking buffer composition (Bovine serum 
albumin 1%, 2%) were used to estimate capability to detect autophagy. Precise protocol can 
be found in Appendix 6.2. Chloroquine, an anti-malarial and anti-inflammatory drug known 
to induce autophagy, was set as positive control and used at 30 µM, 50 µM, 100 µM 
incubated around 16h (overnight). At 30 µM, significantly less autophagosomes were present 
in the cytoplasm of autophagic cells compared to a concentration of chloroquine of 50 µM 
and 100 µM. Small differences were observed between 50 and 100 µM but a concentration of 
100 µM was chosen as positive control in order to induce the maximum number of 
autophagosomes. When 0.5 µg/ml of primary antibody was used, the staining showed less 
specificity for autophagosomes with relatively high cytoplasm signal. A mean of 15% higher 
intensity ratio between autophagosomes and cytoplasm was obtained with a concentration of 
1 µg/ml of primary antibody while other conditions were kept the same. For secondary 
antibody, this ratio was increased by around 12% by using a 200X dilution compared to 
2000X. Augmentation of bovine serum albumin (BSA) in blocking buffer that avoid non-
specific interaction of antibodies, did not increase this ratio as autophagosome intensity was 
also reduced with 2% BSA. The condition in which autophagosomes were the most clearly 
observable and easily segmented (see Figure 15), was thus 100 µM chloroquine, 1 µg/ml of 
primary antibody and 200X secondary antibody.  
As chloroquine appeared to induce autophagosomes formation with overnight incubation, 
other incubation times were not tested. Incubation of primary and secondary antibodies (1h at 
RT, see Appendix 6.2) could also have been increased to enhance the signal but these times 
were kept as low as possible to meet screening requirements and to avoid making longer a 
already time-consuming protocol. Further optimization might be obtained by varying these 
different incubation times. Other parameters like concentration and incubation time of 
membrane permeabilizant (Triton-X100), fixation protocol or number of wash could also be 
investigated. 
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Figure 15. LC3B immunostaining. 
HeLa cells stained with LC3B immunostaining (1 µg/ml primary antibody, 200X 
secondary antibody and blocking buffer 1% BSA). A. Treated with 100 µM 
chloroquine for 16h. B. Control. 
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3.2. Data analysis results 
3.2.1. Wash protocol validation 
Different wash protocols were tested on cells treated with 10 mM CuSO4 for 24h. The percent 
of remaining cells after wash and the wash efficiency represented by the dilution of 
fluorescein are showed in Figure 16. 
BioTek Wash efficiency % remaining cells
Mean SD Mean SD
P1
h=5.25 mmP2
h=6 mm
6.45!% 2.45!% 44.97!% 29.92!%
19.81!% 4.22!% 34.62!% 19.17!%
0!%
25!%
50!%
75!%
100!%
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h=5.25 mm
P2
h=6 mm
34.62!%
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19.81!%
6.45!%
BioTek ELx405™ Microplate Washer 
Wash efficiency
% remaining cells
Wash efficiency
P1
h=2 mm
s=5 uL/s
P2
h=2 mm
s=10 uL/s
P3
h=3 mm
s=5 uL/s
P4
h=3 mm
s=10 uL/s
% dilution
SD
11.29!% 13.97!% 9.52!% 9.98!%
4.15!% 4.78!% 4.53!% 4.27!%
% remaining cell
P1
h=2 mm
s=5 uL/s
P2
h=2 mm
s=10 uL/s
P3
h=3 mm
s=5 uL/s
P4
h=3 mm
s=10 uL/s
Mean % 
remaining cell
SD
102.8!% 74.2!% 43.2!% 82.1!%
23.3!% 32.4!% 9.4!% 12.2!%
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Figure 16. Wash protocol validation results. 
The upper part shows wash efficiency and percentage of remaining cells for wash 
with two different protocols with BioTek ELx405 Microplate Washer at aspiration 
height of 5.25 and 6 mm and lowest traveling speed within well. The lower part, the 
same results with BioMek 3000 at aspiration height of 2 and 3 mm and aspiration 
speed 5 and 10 µl/s. 
ELx405 Microplate Washer removed more than 50% of the dead cells with all the tested 
protocols and was thus not suitable for working with cell viability assays. Other tests were 
performed with BioMek 3000 and decent results were obtained with aspiration height of 
2 mm and aspiration speed of 5 µl/s; with this protocol, almost all dead cells r mained in 
well (mean: 102.8%) and wash efficiency was high with a mean of 11.3% remaining of the 
initial solution. However, high variations regarding cell number were observed in all 
protocols showing that the method was not optimal for reproducibility.  
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3.2.2. Nucleus characterization 
HeLa cell nuclei were analyzed over different experiments. Some features that appeared to be 
relevant to cell viability were extracted and are shown in Figure 17.  
Intensity ratio Mean area Min/Max ratio Granularity
Mean SD Mean SD Mean SD Mean SD
Viable cells
Apoptotic cells
Necrotic cells
1 0.43 124.7 56.4 0.51 0.16 236.4 95.1
2.42 0.72 66.7 21.6 0.36 0.04 496.6 107.9
4.12 0.82 53.1 18.2 0.46 0.03 384.9 76.1
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Figure 17. Nuclear characterization of different features of viable, apoptotic 
and necrotic HeLa cells. 
Inter-experimental analysis of nucleus of viable cells, apoptotic cells (confirmed by 
annexin V conjugate staining) and necrotic cells (confirmed by EthD-1 staining). 
• Intensity ratio: ratio between mean viable cells nucleus intensity and 
apoptotic/necrotic nucleus intensity from the same experiment. 
• Mean area: area determined by ROI area after segmentation in µm2. 
• Min/Max ratio: ratio between pixels that have minimum and maximum 
intensity within ROI after removing the 5th and the 95th percentile of 
intensity histogram. 
• Granularity: average variation between adjacent pixel intensities within a 
ROI normalized to ROI intensity. 
The table below shows the different mean values of the measures and corresponding 
standard deviations. 
Nucleus morphology observed by Hoechst or DAPI staining was changed depending on cell 
state. Intensity of fluorescence signal in apoptotic cells was by a mean of 2.42 higher than in 
viable and 4.12 times for necrotic cells. The area of nuclei of apoptotic and necrotic cells was 
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about two times smaller than viable cells. High variation of viable cell nuclei area could be 
explained by other cell states that result in lower area like mitosis or by segmentation errors. 
To minimize these errors, outlier values were removed from analysis as described in 
Chapter 2.6. Min/Max ratio was not significant although a small effect was observed in 
apoptotic cells. Granularity reflects intra-nuclear intensity variations and was more 
pronounced in apoptotic cells certainly due to the nuclear fragmentation process of apoptosis 
resulting in inhomogeneous nuclear staining. 
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3.2.3. Live/dead assay 
Several experiments of calcein-AM/EthD-1 staining were analyzed. Figure 18 shows intensity 
ratio for calcein and EthD-1 in dead and living cells. These ratios are reasonably high with 
around 5 times more intensity of calcein in living cells and 5 times EthD-1 in dead cells. 
However, z’ factor was negative due to high variability of the two probes. The variability of 
EthD-1 was observable with low signal in cells that had low membrane permeability and very 
high signal in cells with completely compromised plasma membrane, more advanced in the 
death process. For calcein, the variability might be due to segmentation method that estimates 
cytoplasmic area by extension of nucleus and thus the defined cytoplasm ROI might include 
some background signal in some cells, reducing mean intensity of calcein for those one. 
Calcein staining was pretty homogeneous from cell to cell but cells that had smaller rounded-
shape area (mitotic or early dying cells) showed higher intensity of calcein because of a 
higher density of calcein in a smaller area. 
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Figure 18. Calcein/EthD-1 mean intensity in viable and dead cells. 
Ratio between mean whole cell intensity of calcein in viable cells and in dead cells 
(left). Ratio between mean nucleus intensity of EthD-1 in dead cells and in living 
cells (right). The table below shows numerical values. 
The Table 8 shows the different classification of cells in live/dead assay. Living cell event 
was considered when the object was positive for calcein and negative for Ethd-1. As some 
dead cells appeared to have residual calcein staining, cells that were calcein (+) and EthD-1  
(-) were considered as dead. EthD-1 positive and calcein negative were classified as dead 
cells as they had compromised membrane and did not have esterase activity. Objects that 
were negative for calcein and for EthD-1 were set as unknown events and could be 
segmentation errors. 
EthD-1 (+) EthD-1 (-)
Calcein (+)
Calcein (-)
Dead Viable
Dead Unknown  
Table 8. Cell classification in live/dead assay. 
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3.2.4. Annexin V assay 
Annexin V conjugate assay aims to detect apoptosis thanks to translocation of 
phosphatidylserine. An important parameter for this assay is to find a relevant incubation time 
of apoptosis inducer in order to catch this phenomenon. The Figure 19 shows whole cell 
normalized intensities of annexin V conjugate in negative control and cells treated with 10-5 
M staurosporine after different incubation times. A significant difference in signal could be 
observed after 8h and 24h incubation of staurosporine. However the more the time increase, 
the higher variability was present. This reflects the heterogeneity of the cell population that 
have highly variable responses to the stimuli. Discrimination between positive and negative 
cells was observable after 8h and 24h incubation with one standard deviation separation but 
z’ factor was negative due to high variability of positive control. 
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Figure 19. Two populations analysis of annexin V conjugate staining. 
Normalized ratio between mean intensity of annexin V conjugate in negative control 
wells (cells not treated) and mean intensity of cells treated with 10-5 M staurosporine 
after 3h, 4h, 8h and 24h incubation. The table below shows numerical data. 
The same data were analyzed by considering three populations (shown in Figure 20): the 
positive control was divided in the two sub-populations, positive and negative cells for 
ethidium homodimer-1. The results showed that most of the variability in intensity was due to 
the EthD-1 positive cells (late apoptotic/necrotic) cells that had more intense staining for 
annexin V conjugate. As cell membrane is damaged in these cells, annexin V conjugate binds 
to cytoplasmic-oriented phosphatidylserine and thus gives more signal. Variability in this 
signal certainly depends on how far cell death process is advanced in each cell. This explain 
why in Figure 19 the signal after 3h incubation was higher than after 4h, in fact it appeared 
that the more intense signal at 3h was due to dead cells as shown in Figure 20. EthD-1 
negative population showed slightly significant difference in intensity with living cells after 
8h and 24h but z’ factor was negative for this distribution as well as between viable cells and 
EthD-1 positive cells because of high variability. 
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Incubation 
time
Control SD EthD-1 (-) SD EthD-1 (+) SD
3h
4h
8h
24h
1 0.09 1.06 0.10 1.75 0.40
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Figure 20. Three populations analysis of annexin V conjugate staining. 
Normalized ratio between mean intensity of annexin V conjugate in negative control 
wells (cells not treated) with mean intensity of cells treated with 10-5 M 
staurosporine negative for EthD-1 (green) and positive for EthD-1 (yellow) after 3h, 
4h, 8h and 24h incubation. The table below shows numerical data. 
Table 9 shows the different populations of cells that could be classified with annexin V assay. 
Apoptotic event was considered when the object was positive for annexin V and negative for 
EthD-1 (see Chapter 1.3.5). Annexin (+)/EthD-1 (+) cells were classified as necrotic or late 
apoptotic cells as they had compromised plasma membrane. When an object was negative for 
both probes meaning that it had intact membrane and did not show phosphatidylserine 
translocation, it was set as viable. Unknown events were defined as EthD-1 (+) and annexin 
V (-) because they showed plasma membrane permeability but no cytoplasmic-side 
phosphatidylserine staining by annexin V. This contradiction could bring to the conclusion 
that either cell doesn’t have phosphatidylserine in its plasma membrane or this signal is due to 
aggregate of EthD-1 within a living cell. 
EthD-1 (+) EthD-1 (-)
Annexin V (+)
Annexin V (-)
Necrotic/Late 
apoptotic
Apoptotic
Unknown Viable  
Table 9. Cell classification in annexin V assay. 
In summary, the phosphatidylserine translocation was observable with one standard deviation 
criteria showing proof of principle of the detection method. The separation between early 
apoptotic and late apoptotic/necrotic cells was achievable from 8h incubation with 10-5 M 
staurosporine. Nevertheless, the three standard deviations separation required in high 
throughput screening assays was not reached and the protocol need more optimization to be 
used in high content assay. In fact, the signal for apoptotic cells was not high enough with the 
used method. Improvements could be done in segmentation as with current method the signal 
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is measured in whole cell while annexin V conjugate is located on cell membrane. However, 
plasmic membrane segmentation was hard due to heterogeneous cell shape. Z stack imaging 
could increase the whole cell signal by gathering fluorescence emission at different levels so 
that membrane intensity is averaged in the cytoplasm of the cell but this method would highly 
increase acquisition time. 
 
 
 
 
 
 
  
  36     
3.2.5. LC3B assay 
LC3B immunostaining was performed to detect autophagosomes formation in cells treated 
with 100 µM chloroquine. Image segmentation process is depicted in Figure 21 and exact 
parameters can be found in Appendix 6.3. This segmentation seemed to efficiently enhance 
contrast of autophagosomes in cytoplasmic part of cells thanks to different image processing 
algorithms. As shown in the final mask, autophagosomes (red dots) were present in the 
cytoplasm of cells treated with chloroquine. In control, some spots were found but were 
excluded from analysis as they were mainly localized in nucleus part of the cells and sub-
objet analyzing was restricted to cytoplasm ROI. This signal could represent nucleolus or 
noise for some of these spots present in the background. 
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Figure 21. LC3B immunostaining segmentation process. 
A two-steps segmentation was used to detect autophagosomes in cytoplasm of 
autophagic cells. The first step defined nucleus with Hoechst staining and cytoplasm 
thanks to residual fluorescence of immunostaining in this part of the cell. The 
second step aimed to sharpen autophagosomes in order to discriminate them from 
cytoplasm fluorescence. RB 5X5 removed cytoplasmic fluorescence and a sharpen 
hat filter was used to enhance contrast of autophagosomes. The final mask shows 
detected autophagosomes (red) and cytoplasm mask (blue). Measurements of 
autophagosomes properties were done only in cytoplasmic part. 
Several features were extracted from image segmentation in order to find the most relevant 
parameter that characterizes autophagic cells. Their comparison in control, cells treated with 
50 µM and 100 µM chloroquine for 16h is shown in Figure 22.  
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Control 50 μM chloroquine 100 μM chloroquine
Mean SD Mean SD Mean SD
Cytoplasm 
intensity
Dot intensity
Dot total area
Dot count
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Figure 22. Comparison of features extracted from LC3B staining in control, 
cells treated with 50 and 100 µM chloroquine. 
Mean cytoplasm intensity, autophagosomes intensity, total area and count extracted 
from cells stained with 1 µg/ml LC3B antibody and 200X secondary antibody. 
Cytoplasmic unspecific staining was slightly higher in control and might be due to higher 
availability of antibodies as they were not concentrated on autophagosomes. Intensity ratio 
between mean cytoplasmic intensity and mean dot intensity in autophagic cells was of 
respectively 1.67 and 1.59 in cells treated with 50 µM and 100 µM chloroquine. With the 
used segmentation method, the mean number of dot in control was of zero. In cells treated 
with 50 µM chloroquine, a mean of 3.58 autophagosomes were detected in autophagic cells 
and this mean was increased to 4.05 autophagosomes in cells treated with 100 µM 
chloroquine. Nevertheless, this parameter showed high variability with up to 41 
autophagosomes detected within a single cell, leading to negative z’ factor. Autophagosomes 
total area in cytoplasm showed similar results as it is closely related to number of 
autophagosomes. In the same way even with lower variabitity, z’ factor was negative.  
Observations during segmentation process revealed that cells that appeared dead (round- 
shaped) had higher uniform cytoplasmic intensity. Segmentation of these cells indicated that 
high number of autophagosomes were present in these cells. However these detections were 
only due to the mean higher intensity of the staining and were not dots as they appeared in 
autophagic cells. Investigation of LC3B immunostaining has to be performed on necrotic and 
apoptotic cells to get their response to this assay and these observations show that 
segmentation method is not robust enough to discriminate between the different cellular 
phenotype that could be present in experiments. 
To minimize false positive results, cells that had cytoplasmic intensity higher than three 
standard deviations apart from the mean intensity were excluded from analysis. The Table 10 
show the classification of cell used in LC3B assay. 
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Normal cytoplasmic 
intensity
High cytoplasmic 
intensity
Presence of 
autophagosomes
Absence of 
autophagosomes
Autophagic Excluded
Viable Excluded
 
Table 10. Cell classification in LC3B assay. 
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3.3. Cell death inducers 
Toxicity of different cell death inducer was determined using alamarBlue assay with three 
different protocols (see Chapter 2.2). Dose-response curves were obtained by fitting with 
GraphPad Prism. An example for one of the compound (terpinen-4-ol) is given in Figure 
23. 
Concentration
Terpinen-4-ol 48h cells 
before
Mean SD
3.00E-01
1.00E-01
3.00E-02
1.00E-02
3.00E-03
1.00E-03
3.00E-04
1.00E-04
99.4!% 0.4!%
100.0!% 0.2!%
99.6!% 0.2!%
99.5!% 0.9!%
99.6!% 0.1!%
16.3!% 6.8!%
12.3!% 9.3!%
10.0!% 6.8!%
Concentration
Terpinen-4-ol 24h cells 
before
Mean SD
3.00E-01
1.00E-01
3.00E-02
1.00E-02
3.00E-03
1.00E-03
3.00E-04
1.00E-04
101.8!% 1.1!%
102.3!% 1.9!%
102.1!% 1.1!%
46.5!% 9.7!%
23.4!% 26.8!%
6.6!% 4.9!%
14.4!% 14.8!%
3.6!% 5.8!%
Concentration
Terpinen-4-ol 24h with 
cells
Mean SD
6.00E-01
1.00E-01
7.00E-02
3.00E-02
1.00E-02
7.00E-03
3.00E-03
1.00E-03
3.00E-04
1.00E-05
3.00E-06
1.00E-06
3.00E-07
1.00E-07
3.00E-08
1.00E-08
3.00E-09
1.00E-09
115.7!% 8.0!%
107.85!% 3.12!%
107.8!% 3.1!%
107.5!% 3.2!%
107.60!% 3.08!%
107.6!% 3.3!%
106.5!% 4.1!%
41.1!% 5.7!%
6.1!% 8.3!%
1.6!% 3.1!%
-2.6!% 4.7!%
0.4!% 5.1!%
-1.5!% 7.2!%
-1.4!% 7.2!%
-1.4!% 4.8!%
1.3!% 5.0!%
-4.2!% 6.3!%
-7.8!% 5.8!%
-25!%
0!%
25!%
50!%
75!%
100!%
125!%
1E-05 1E-04 1E-03 1E-02 1E-01 1E+00
Terpinen-4-ol
To
xi
ci
ty
Concentration [M]
Terpinen-4-ol 24h with cells
Terpinen-4-ol 24h cells before
Terpinen-4-ol 48h cells before
Curve Terpinen-4-ol 24h with cells
Curve Terpinen-4-ol 48h cells before
Curve Terpinen-4-ol 24h cells before
Decades Concentration Curve 
Terpinen-4-ol 
24h with cells
Curve 
Terpinen-4-ol 
48h cells before
Curve 
Terpinen-4-ol 
24h cells before
-10.00 1.00E-10 -1.18!% 5.00!% 2.91!%
-9.90 1.26E-10 -1.18!% 5.00!% 2.91!%
-9.80 1.58E-10 -1.18!% 5.00!% 2.91!%
-9.70 2.00E-10 -1.18!% 5.00!% 2.91!%
-9.60 2.51E-10 -1.18!% 5.00!% 2.91!%
-9.50 3.16E-10 -1.18!% 5.00!% 2.91!%
-9.40 3.98E-10 -1.18!% 5.00!% 2.91!%
-9.30 5.01E-10 -1.18!% 5.00!% 2.91!%
-9.20 6.31E-10 -1.18!% 5.00!% 2.91!%
-9.10 7.94E-10 -1.18!% 5.00!% 2.91!%
-9.00 1.00E-09 -1.18!% 5.00!% 2.91!%
-8.90 1.26E-09 -1.18!% 5.00!% 2.91!%
-8.80 1.58E-09 -1.18!% 5.00!% 2.91!%
-8.70 2.00E-09 -1.18!% 5.00!% 2.91!%
-8.60 2.51E-09 -1.18!% 5.00!% 2.91!%
-8.50 3.16E-09 -1.18!% 5.00!% 2.91!%
-8.40 3.98E-09 -1.18!% 5.00!% 2.91!%
-8.30 5.01E-09 -1.18!% 5.00!% 2.91!%
-8.20 6.31E-09 -1.18!% 5.00!% 2.91!%
-8.10 7.94E-09 -1.18!% 5.00!% 2.91!%
-8.00 1.00E-08 -1.18!% 5.00!% 2.91!%
-7.90 1.26E-08 -1.18!% 5.00!% 2.91!%
-7.80 1.58E-08 -1.18!% 5.00!% 2.91!%
-7.70 2.00E-08 -1.18!% 5.00!% 2.91!%
-7.60 2.51E-08 -1.18!% 5.00!% 2.91!%
-7.50 3.16E-08 -1.18!% 5.00!% 2.91!%
-7.40 3.98E-08 -1.18!% 5.00!% 2.91!%
-7.30 5.01E-08 -1.18!% 5.00!% 2.91!%
-7.20 6.31E-08 -1.18!% 5.00!% 2.91!%
-7.10 7.94E-08 -1.18!% 5.00!% 2.91!%
-7.00 1.00E-07 -1.18!% 5.00!% 2.91!%
-6.90 1.26E-07 -1.18!% 5.00!% 2.91!%
-6.80 1.58E-07 -1.18!% 5.00!% 2.91!%
-6.70 2.00E-07 -1.18!% 5.00!% 2.91!%
-6.60 2.51E-07 -1.18!% 5.00!% 2.91!%
-6.50 3.16E-07 -1.18!% 5.00!% 2.91!%
-6.40 3.98E-07 -1.18!% 5.00!% 2.91!%
-6.30 5.01E-07 -1.18!% 5.00!% 2.91!%
-6.20 6.31E-07 -1.18!% 5.00!% 2.91!%
-6.10 7.94E-07 -1.18!% 5.00!% 2.91!%
-6.00 1.00E-06 -1.18!% 5.00!% 2.91!%
-5.90 1.26E-06 -1.18!% 5.00!% 2.91!%
-5.80 1.58E-06 -1.18!% 5.00!% 2.91!%
-5.70 2.00E-06 -1.18!% 5.00!% 2.91!%
-5.60 2.51E-06 -1.18!% 5.00!% 2.91!%
-5.50 3.16E-06 -1.18!% 5.00!% 2.91!%
-5.40 3.98E-06 -1.18!% 5.00!% 2.91!%
-5.30 5.01E-06 -1.18!% 5.00!% 2.91!%
-5.20 6.31E-06 -1.18!% 5.00!% 2.91!%
-5.10 7.94E-06 -1.18!% 5.00!% 2.91!%
-5.00 1.00E-05 -1.18!% 5.00!% 2.91!%
-4.90 1.26E-05 -1.18!% 5.00!% 2.91!%
-4.80 1.58E-05 -1.18!% 5.00!% 2.91!%
-4.70 2.00E-05 -1.18!% 5.00!% 2.91!%
-4.60 2.51E-05 -1.18!% 5.00!% 2.91!%
-4.50 3.16E-05 -1.18!% 5.00!% 2.92!%
-4.40 3.98E-05 -1.18!% 5.00!% 2.93!%
-4.30 5.01E-05 -1.17!% 5.00!% 2.93!%
-4.20 6.31E-05 -1.17!% 5.00!% 2.95!%
-4.10 7.94E-05 -1.15!% 5.00!% 2.97!%
-4.00 1.00E-04 -1.13!% 5.00!% 2.99!%
-3.90 1.26E-04 -1.07!% 5.00!% 3.03!%
-3.80 1.58E-04 -0.96!% 5.01!% 3.08!%
-3.70 2.00E-04 -0.73!% 5.01!% 3.16!%
-3.60 2.51E-04 -0.26!% 5.03!% 3.27!%
-3.50 3.16E-04 0.70!% 5.08!% 3.43!%
-3.40 3.98E-04 2.61!% 5.18!% 3.66!%
-3.30 5.01E-04 6.35!% 5.45!% 3.98!%
-3.20 6.31E-04 13.26!% 6.09!% 4.44!%
-3.10 7.94E-04 24.91!% 7.61!% 5.10!%
-3.00 1.00E-03 41.77!% 11.11!% 6.02!%
-2.90 1.26E-03 61.44!% 18.63!% 7.33!%
-2.80 1.58E-03 79.39!% 32.52!% 9.14!%
-2.70 2.00E-03 92.44!% 52.31!% 11.63!%
-2.60 2.51E-03 100.45!% 72.10!% 15.01!%
-2.50 3.16E-03 104.86!% 85.99!% 19.46!%
-2.40 3.98E-03 107.14!% 93.51!% 25.17!%
-2.30 5.01E-03 108.29!% 97.01!% 32.21!%
-2.20 6.31E-03 108.86!% 98.53!% 40.50!%
-2.10 7.94E-03 109.14!% 99.17!% 49.71!%
-2.00 1.00E-02 109.27!% 99.44!% 59.35!%
-1.90 1.26E-02 109.34!% 99.54!% 68.81!%
-1.80 1.58E-02 109.37!% 99.59!% 77.51!%
-1.70 2.00E-02 109.39!% 99.61!% 85.08!%
-1.60 2.51E-02 109.39!% 99.61!% 91.32!%
-1.50 3.16E-02 109.40!% 99.62!% 96.26!%
-1.40 3.98E-02 109.40!% 99.62!% 100.04!%
-1.30 5.01E-02 109.40!% 99.62!% 102.86!%
-1.20 6.31E-02 109.40!% 99.62!% 104.92!%
-1.10 7.94E-02 109.40!% 99.62!% 106.41!%
-1.00 1.00E-01 109.40!% 99.62!% 107.47!%
-0.90 1.26E-01 109.40!% 99.62!% 108.23!%
-0.80 1.58E-01 109.40!% 99.62!% 108.76!%
-0.70 2.00E-01 109.40!% 99.62!% 109.13!%
-0.60 2.51E-01 109.40!% 99.62!% 109.39!%
-0.50 3.16E-01 109.40!% 99.62!% 109.58!%
-0.40 3.98E-01 109.40!% 99.62!% 109.71!%
-0.30 5.01E-01 109.40!% 99.62!% 109.79!%
-0.20 6.31E-01 109.40!% 99.62!% 109.86!%
-0.10 7.94E-01 109.40!% 99.62!% 109.90!%
-0.00 1.00E+00 109.40!% 99.62!% 109.93!%
0.10 1.26E+00 109.40!% 99.62!% 109.95!%
0.20 1.58E+00 109.40!% 99.62!% 109.97!%
0.30 2.00E+00 109.40!% 99.62!% 109.98!%
0.40 2.51E+00 109.40!% 99.62!% 109.98!%
0.50 3.16E+00 109.40!% 99.62!% 109.99!%
0.60 3.98E+00 109.40!% 99.62!% 109.99!%
0.70 5.01E+00 109.40!% 99.62!% 109.99!%
0.80 6.31E+00 109.40!% 99.62!% 110.00!%
Equation 
Terpinen-4-ol 
24h with cells
Equation 
Terpinen-4-ol 
48h cells 
before
Equation 
Terpinen-4-ol 
24h cells 
before
Bottom
Top
log(EC50)
HillSlope
EC50
R2
-0.01 0.05 0.03
1.09 1.00 1.10
-2.94 -2.70 -2.03
3.13 3.87 1.57
1.16E-03 2.49E-03 6.83E-03
0.997 0.607 0.903
 
Figure 23. Toxicity of terpinen-4-ol. 
The figure shows dose-response curves with different protocols for terpinen-4-ol. 
Curves were fitted with GraphPad Prism. 
Thanks to these curves, IC50 (the concentration of compound at which half of the cell 
population was dead) for each cell death inducer was determined and is shown in Table 11. 
Product
IC50 [M]
Incubated 24h 
with cells
Incubated 48h 
cells plated 
before
Incubated 24h 
cells plated 
beforeEDTA
Valproïc acid
Sodium azide
Terpinen-4-ol
Gambogic acid
Staurosporine
Celastrol
Biozidal
1.0E-03 8.8E-04 1.4E-03
6.2E-02 2.0E-03 -
6.5E-03 5.2E-03 1.7E-02
1.2E-03 2.5E-03 6.8E-03
1.3E-06 1.7E-06 5.4E-06
5.4E-07 1. E-06 1.8E-06
2.5E-06 5. E-06 1.3E-05
0.1!% - -  
Table 11. IC50 of different cell death inducers. 
IC50 determined with alamarBlue assay with the different protocols described in 
Chapter 2.2. 
With 24h incubation and cells plated before, valproïc acid did not reach maximal toxicity with 
the highest concentration used (10-1 M, toxicity 26.2%) and curve fitting was thus 
meaningless. Biozidal, a disinfectant spray used to keep sterility of materials in laminar flow 
hood, was tested only with 24h incubation added at the same time than the cells in the plate to 
get an idea of its toxicity. This substance killed all cells at a dilution of only 0.25% volume 
and could thus induce toxicity if involuntarily diluted with cell medium. 
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Live/dead assay was performed with these cell death inducers at a concentration close to 
maximal toxicity. Half of the wells of this plate were analyzed with alamarBlue assay and 
results are shown in Table 12. 
Product
Concentration 
[M]
% of viable 
cells
% of dead 
cells
% of 
unknown
Toxicity 
(Live/Dead 
assay)
Toxicity 
(alamarBlue® 
assay)
Control -
EDTA 3E-03
Valproïc acid 1E-01
Sodium azide 1E-01
Terpinen-4-ol 3E-02
Gambogic acid 1E-05
Staurosporine 1E-05
Celastrol 3E-05
89.2!% 3.3!% 7.4!% 0!% 0!%
71.4!% 21.3!% 7.3!% 18.0!% 81.6!%
19.4!% 74.7!% 5.9!% 71.4!% 85.8!%
39.3!% 51.7!% 9.0!% 48.4!% 93.5!%
8.5!% 82.2!% 9.3!% 78.8!% 95.4!%
7.0!% 89.0!% 4.0!% 85.7!% 90.0!%
47.6!% 48.2!% 4.2!% 44.9!% 90.8!%
1.7!% 94.8!% 3.5!% 91.4!% 92.8!%  
Table 12. Comparison of live/dead and alamarBlue  assay for different cell 
death inducers. 
Toxicity of different compounds incubated 24h measured with live/dead assay and 
alamarBlue assay on the same plate. Definition of viable cells, dead cells and 
unknown events are explained in Chapter 3.2.3, Table 8.  
Unknown events appended at relatively low rate with a mean of 6.3% for all conditions. As 
shown in the two last columns of Table 12, high difference of toxicity between live/dead 
assay and alamarBlue assay was observed for EDTA, sodium azide and staurosporine. For 
other compound, toxicity was more or less comparable. This could be explained by the fact 
that live/dead assay and alamarBlue assay have different definition of viable cells. In fact, 
early dying cells could still have reducing power to convert resazurin to resorufin while 
having only low remaining esterase activity. However, this phenomenon would hardly bring a 
difference of more than 60% in toxicity (for EDTA) and other factors could have influenced 
this difference. The various toxic activities of the different compounds (e.g. kinase inhibition 
for staurosporine or regulation of apoptosis pathway for GBA) that act on different cell 
pathway could also bring a faster reduction of intracellular esterase activity while keeping 
reducing environment in the cell. Finally, the compounds could directly interact with the 
dyes, creating not representative response of the biological system. 
Annexin V assay was performed on cell death inducers. An incubation time of the compounds 
of 6h30 was chosen and results are shown in Table 13. 
Product
Concentration 
[M]
% of necrotic 
cells
% of apoptic 
cells
% of 
unknown
% of viable
Control -
EDTA 3E-03
Valproïc acid 1E-01
Sodium azide 1E-01
Terpinen-4-ol 3E-02
Gambogic acid 1E-05
Staurosporine 1E-05
Celastrol 3E-05
2.2!% 3.5!% 0.7!% 93.6!%
8.4!% 14.5!% 1.5!% 75.6!%
29.1!% 11.6!% 5.8!% 53.4!%
16.9!% 39.7!% 3.6!% 39.8!%
10.8!% 4.8!% 39.1!% 45.4!%
13.8!% 12.0!% 5.5!% 68.7!%
5.7!% 49.3!% 1.0!% 44.0!%
45.6!% 3.9!% 8.6!% 41.9!%  
Table 13. Annexin V assay for different cell death inducers. 
Percentage of necrotic, apoptotic and viable cells induced after 6h30 incubation with 
different compounds. Unknown category is defined in Chapter 3.2.4, Table 9. 
Unknown event proportions were low for all compounds except from terpinen-4-ol. In these 
wells, EthD-1 showed unspecific staining in cells that appeared viable while annexin V 
staining was inexistent. Thus, these cells were EthD-1 (+)/Annexin V (-) and were classified 
as unknown events. With high percentage of unknown events, terpinen-4-ol toxicity 
information might not be reliable. 
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Incubation time of 6h30 might have been not long enough as only around 50% of cells treated 
with staurosporine were in apoptotic state and this compound was considered as positive 
control. An incubation time of 8h could lead to more representative results as described in 
Chapter 3.1.4. However in these conditions, sodium azide appeared to induce the highest 
proportion of apoptotic cells after staurosporine. Gambogic acid, a molecule known to induce 
apoptosis, did not show specific induction of this cell death with an equal proportion of 
necrotic and apoptotic cells recorded. EDTA triggered slightly more the apoptotic pathway 
than necrosis. VPA and terpinen-4-ol killed the cells mostly by necrosis with about two times 
more dying cells by the type of death. Celastrol, an anti-cancer drug known to act as anti-
proliferative agent by inducing apoptosis, showed only negligible proportion of apoptotic 
cells. Especially when compared to control wells, this proportion was lowered to almost zero. 
This compound induced the highest proportion of necrotic cells. This contradiction could be 
explained by the fact that the necrotic and the late apoptotic populations are not discriminated 
in this assay and Celastrol could induce apoptosis in a shorter way than the used incubation 
time. The apoptotic process might have been more advanced and plasma membrane integrity 
was already compromised when the assay was performed. Thus, different timeframes and 
compound concentrations have to be investigated to get reliable information of mechanism 
leading to cell death. 
LC3B immunostaining was used to detect autophagy-inducing compounds. Results are shown 
in Table 14. 
Product
Concentration 
[M]
% of 
autophagic 
cells
% of viable 
cells
% of 
excluded
Control -
EDTA 3E-03
Valproïc acid 1E-01
Sodium azide 1E-01
Terpinen-4-ol 3E-02
Gambogic acid 1E-05
Staurosporine 1E-05
Celastrol 3E-05
Chloroquine 1E-04
6.4!% 91.2!% 2.4!%
21.6!% 70.3!% 8.1!%
27.3!% 48.6!% 24.2!%
13.1!% 81.5!% 5.4!%
0.0!% 99.1!% 0.9!%
0.2!% 80.7!% 19.1!%
9.5!% 81.8!% 8.7!%
0.4!% 84.8!% 14.8!%
59.0!% 40.5!% 0.4!%  
Table 14. LC3B immunostaining of cells treated with different cell death 
inducers. 
Percentage of autophagic and viable cells induced by 16h incubation with different 
compounds. Excluded event and cell classification are explained in Chapter 3.2.5, 
Table 10. 
The positive control, chloroquine used at a concentration of 100 µM, induced 59% of 
autophagic cells with low number of excluded events. In wells treated with terpinen-4-ol, 
gambogic acid and celastrol, negligible number of autophagic events were recorded. 
Staurosporine and sodium azide showed relatively low number of autophagosome-containing 
cells. One fifth of the cells treated with EDTA were engaged in the autophagic process. The 
compound that induced the most autophagy was VPA and this correlates with information 
gathered on this substance. However, proportion of excluded events was high for VPA, 
gambogic acid and celastrol and the robustness of the detection method is discussed in 
Chapter 3.2.5. 
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4. Discussion 
High content screening is a powerful tool for generating data on fluorescent cell-based assays. 
In this work, several fluorescent probes for cell viability were tested, optimized and discussed 
for high content applications. Cell death is a complex mechanism highly regulated by 
multiple molecules that act on different cell compartments. HCS assays can be multiplexed 
and have thus great potential to assess cell death mechanisms by reporting different biological 
activities. In drug discovery, toxicological studies are of high importance as harmful effects of 
drug candidates have to be well characterized so they can become a treatment. 
The importance of liquid handling validation has been highlighted. In fact when working with 
adherent cells in multiwell plates, dead or dying cells tends to detach from the bottom of the 
wells and are thus easily removed by liquid aspiration. By removing all or part of the dead 
cell population, the analyzed sample becomes biased as only living cells are remaining. This 
effect might be monitored by cell number but high variability is expected in this parameter 
when working with toxic molecules. Populations homogeneity within single well has also to 
be taken in account; liquid handling can induce concentration of detached cells in an area of 
the well. As imaging whole well can produce a consequent volume of data, the part of the 
well to be imaged has to be chosen judiciously or homogenization has to be performed. If 
these effects are deeply studied, they might be compensated in data analysis to estimate total 
toxicity of the compounds. The carelessness of these phenomenons could bring to dramatic 
erroneous conclusions on the toxicity of the substances tested. 
Live/dead assay using calcein/EthD-1 showed significant difference in signal between living 
and dead cells but high variability. Dual staining was performed on HeLa cells to discriminate 
the two populations. Residual signal of calcein was observed in dead cells and intensity 
variations in living cells brought high variability in measured signal. The segmentation 
method might have contribute to this variation due to inclusion of background signal in the 
whole cell ROI. Different signal intensities were observed with EthD-1 staining and can 
depend on how the cell death process is advanced. The information obtained with this assay 
was compared to alamarBlue assay on a set of toxic compounds. Significant differences of 
toxicity were defined by the two assays for some compounds. This result was partly explained 
by the fact that the two assays target different mechanisms to assess cell viability. 
AlamarBlue and calcein/EthD-1 assays both aim to determine viability of a cell population. 
However, the data obtained with alamarBlue assay was not less informative than with 
calcein/EthD-1 staining and this assay might not be optimal solution for live/dead assay in 
screening. This type of assay is highly informative in tissues or organs staining as spatial 
distribution of viable and dead cells can be determined. The potential of calcein and EthD-1 
staining in high content screening is the multiplexed application in order to determine cell 
viability while using an assay that tests other cell mechanism. For this purpose, starting 
conditions have been defined for both probes but further optimized with the multiplexed dye 
is needed to get lower variability. 
Apoptosis detection in HeLa cells was tested with FLICA and annexin V conjugate assay. 
FLICA staining showed low signal-to-background ratio and separation between positive and 
negative populations was not achievable. Apoptotic cells were successfully stained with 
annexin V conjugate assay and significant difference in signal was observed with living cells. 
This assay allowed to distinguish three cell populations: living cells, early apoptotic cells and 
necrotic/late apoptotic cells. With this assay, apoptotic cells were detectable only until plasma 
membrane rupture; after this event, necrotic and apoptotic cells were not separable. High 
variability was present within control cell population and part of this variation of signal was 
due to the underlying biological process. In fact, phosphatidylserine translocation appends 
gradually with loss of flippases activity and therefore the number of available targets for 
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annexin V on the outer-side of plasma membrane increases with the advancement of the 
apoptotic process. As apoptosis activation time is not equal for each single cell even under the 
same experimental conditions, the staining intensity naturally varies upon different cells. An 
other source of variations between positive cells was segmentation method used. Whole cell 
measurements were taken and annexin V conjugate is localized on cell membrane. Different 
toxic compounds were tested with this assay and some substances known to induce apoptosis 
were negative. This could be explained by the fact that staurosporine was used as control to 
induce apoptosis and the assay was optimized with this inductor. Other compounds might 
trigger apoptosis in a different timeframe and show slight variation in the phenotype of 
apoptotic cells. Annexin V conjugate is a promising assay to detect apoptosis but optimization 
to minimize variability has to be performed so that this assay reaches screening requirements. 
LC3B immunostaining showed an observable difference in phenotypes between control and 
cells treated with chloroquine. Autophagosomes were detected in the cytoplasm of autophagic 
cells induced by overnight incubation of 100 mM of chloroquine with a decent signal ratio 
between autophagosomes and cytoplasm. The developed image analysis method successfully 
segmented autophagosomes in the cytoplasmic part of autophagic cells while no signal was 
detected in negative control wells. Segmentation method failed autophagosomes detection in 
dead cells due to higher cytoplasmic intensity and these cells had to be excluded from 
analysis. Immunostaining required long and complex protocol with more than 2h30 total 
incubation times and seven wash steps. This protocol makes LC3B assay difficult to be 
performed at high throughput and fluorescent conjugated antibody against LC3B would 
reduce number of steps and incubation times. More, permeabilization of cell membrane was 
needed to allow antibody to enter the cells. This step made annexin V staining meaningless 
and cell membrane permeability assessments were no more feasible. Thus if this assay want 
to be combined with apoptosis detection, annexin V assay has to be acquired before LC3B 
staining and therefore doubling acquisition time and lengthening protocol. This constraint 
makes the combined autophagy/apoptosis detection unachievable at high throughput with 
these assays and compatible only with small set of compounds. 
Nucleus analysis showed significant difference in area, intensity and granularity between 
living, apoptotic and necrotic cells. This information could be used to get insight about cell 
state if well characterized and compared to appropriate controls. As nuclear stains are present 
is almost all high content assays to get cell number and position, analysis of nucleus could be 
a powerful method to get a hint of death mechanism at high throughput and generates no 
supplementary material costs than the planned assay. Time and resources of image and data 
analysis would be reasonably increased compared to the importance of the data extracted. 
This method could typically be used in primary/secondary screen and give a fair estimation of 
the toxicity of the hits while assessing at the same time their activity on the biological target 
with the combined assay. Further toxicity studies can then be performed on selected hits with 
more informative tests on death mechanism. Similarly to nuclear stains, cytoplasmic probes 
defining cell shape could also give significant information on the viability of the cells with 
relevant features extracted from image segmentation. 
A common question raised by the cell death assays performed was time at which the 
phenomenon tested append. For instance in annexin V assays, the phosphatidylserine 
translocation was observable only during a restrict timeframe defined as early apoptosis state. 
As shown in the different experiments, these timeframes mainly depend on two parameters 
that are concentration of inducer and incubation time but variability was observed from cell to 
cell under the same conditions. This means that end-point single condition usually performed 
in primary/secondary screen is not sufficient to assess toxicity of the compounds tested and 
would create false negative results. Gradient of concentrations and different time points have 
to be investigated to precisely determine potential harmful effect of a substance. These 
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experiments would generate high cost and time at high throughput and are thus suitable only 
for late state development like hits-to-leads studies. Also, several cellular mechanisms might 
be tested for the same type of death as different results can be obtained. This is illustrated by 
the results obtained on the set of toxic compounds where contradictory conclusions on cell 
viability were drawn using two different assays to get the same data. 
Single cell classification was hard as various responses were observed to the different assays. 
At larger throughput, more phenotypes would be encountered and characterization have to be 
robust with narrow ranges for positive and negative cells. A multiparametric classification 
could give better results with less false positive and false negative events thanks to the 
multiplication of the interval of confidence in which cells are classified. Consequently, an 
important bottleneck of high content screening assays is the variability of the data due to 
diversity of living systems.  
This work allowed to set up conditions for several fluorescent cell viability probes and 
conclude about their potential applications in high content screening. The observation and 
classification of dead or dying cells appeared to be a difficult task at high throughput as cell 
death is a complex mechanism and needs to be addressed in a thoughtful way. Deeper 
investigations of the image analysis, data handling and phenotype classification solutions 
have to be performed to be applicable at large scale. 
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6. Appendices 
6.1. Cell death inducers 
 
The following sheets describe different products used to induce cell death in HeLa cells. 
 
• EDTA 
• Gambogic acid 
• Sodium azide 
• Staurosporine 
• Terpinen-4-ol 
• Valproïc acid 
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Product information sheet : EDTA 
 
Name: Ethylenediaminetetraacetic acid (EDTA) 
Information: Chelating agent. Used in cell culture to bind calcium ions and prevent  
 cadherins interactions, thus facilitating detachment of adherent cells. 
Chemical formula:  C10H16N2O8 
 
EDTA chemical structure. 
 
Molecular weight:  292.24 g mol−1 
Solubility: 10-1 M in H2O 
Toxicity data: Toxicity according to 3 protocols: 
• 24h incubation added with the cells 
• 24h incubation added 24h after plating cells 
• 48h incubation added 24h after plating cells  
 
 
 EDTA 24h 
with cells 
EDTA 48h 
cells before 
EDTA 24h 
cells before 
EC50 1.03E-03 8.83E-04 1.36E-03 
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Product information sheet : Gambogic acid 
 
Name: Gambogic acid 
Information: Natural product isolated from the resin of plants Garcinia species. 
Known to induce apoptosis by upregulating Bax and inhibiting anti- 
 apoptotic Bcl-2 proteins expression. 
Chemical formula:  C38H44O8 
 
 
Gambogic acid chemical structure 
 
Molecular weight:  628.8 g mol−1 
Solubility: 10−2 M in DMSO 
Toxicity data: Toxicity according to 3 protocols: 
• 24h incubation added with the cells 
• 24h incubation added 24h after plating cells 
• 48h incubation added 24h after plating cells  
 
 
 GBA 24h 
with cells 
GBA 48h 
cells before 
GBA 24h 
cells before 
EC50 1.25E-06 1.75E-06 5.38E-06 
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Product information sheet : Sodium azide 
 
Name: Sodium azide 
Information: Inhibits cytochrome oxydase by binding to the heme factor. It is very 
toxic, mutagen and preservative. 
 
Chemical formula:  NaN3 
 
 
Sodium azide chemical structure 
 
Molecular weight:  65.0099 g mol−1 
Solubility: 6.4 M in H2O 
 5⋅10-2 in alcohol 
Toxicity data: Toxicity according to 3 protocols: 
• 24h incubation added with the cells 
• 24h incubation added 24h after plating cells 
• 48h incubation added 24h after plating cells  
 
 
 NaN3 24h 
with cells 
NaN3 48h 
cells before 
NaN3 24h 
cells before 
EC50 4.57E-03 5.21E-03 1.66E-02 
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Product information sheet : Staurosporine 
 
Name: Staurosporine 
Information: Natural product isolated from bacterium Streptomyces staurosporeus, 
this protein is inhibiting protein kinases by preventing ATP from 
binding to them. It is known to induce apoptosis. 
 
Chemical formula:  C28H26N4O3 
 
 
Staurosporine chemical structure 
 
Molecular weight:  466.53 g mol−1 
Solubility: 10−2 M in DMSO 
Toxicity data: Toxicity according to 3 protocols: 
• 24h incubation added with the cells 
• 24h incubation added 24h after plating cells 
• 48h incubation added 24h after plating cells  
 
 
 Stauro 24h 
with cells 
Stauro 48h 
cells before 
Stauro 24h 
cells before 
EC50 1.05E-06 1.58E-06 3.55E-06 
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Product information sheet : Terpinen-4-ol 
 
Name: Terpinen-4-ol 
Information: Natural product isolated from tea tree oil, an oil derived from an 
Australian plant Melaleuca alternifolia. It is used for its anti-
microbial, anti-inflammatory and anti-cancer effect although its 
mechanism of action is not well known. 
 
Chemical formula:  C10H18O 
 
 
Terpinen-4-ol chemical structure 
 
Molecular weight:  154.25 g mol−1 
Solubility: 3 10−3 M in H2O 
Toxicity data: Toxicity according to 3 protocols: 
• 24h incubation added with the cells 
• 24h incubation added 24h after plating cells 
• 48h incubation added 24h after plating cells  
 
 
 T4O 24h 
with cells 
T4O 48h 
cells before 
T4O 24h 
cells before 
EC50 1.16E-03 2.00E-03 9.33E-03 
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Product information sheet : Valproïc acid 
 
Name: Valproïc acid 
Information: Inhibitor of histone deacetylase and used as anticonvulsant and mood-
stabilizing drug. It has been shown to induce autophagy. 
 
Chemical formula:  C8H12O2 
 
Valproïc acid chemical structure 
 
Molecular weight:  144.21 g mol−1 
Solubility: 1 M in H2O 
Toxicity data: Toxicity according to 3 protocols: 
• 24h incubation added with the cells 
• 24h incubation added 24h after plating cells 
• 48h incubation added 24h after plating cells  
 
 
 VPA 24h 
with cells 
VPA 48h 
cells before 
VPA 24h 
cells before 
EC50 2.51E-02 3.98E-03 - 
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6.2. Staining protocols 
 
Hoechst 
0. At J-1, plate 3’000 HeLa cells per well. 
1. Add Hoechst 33342 staining solution as 10X concentrated for a final concentration of 
1 µg/ml. A 1X concentrated solution could also be used after removing cell medium. 
2. Incubate at 37°C for minimum 15 min or at RT for 30 min. 
 
DAPI 
0. At J-1, plate 3’000 HeLa cells per well. 
1. Add DAPI staining solution as 10X concentrated for a final concentration of 10 µg/ml. 
A 1X concentrated solution could also be used after removing cell medium. 
2. Incubate at 37°C for minimum 15 min or at RT for 30 min. 
3. Wash 1X with 100 µl PBS per well. 
 
Calcein 
0. At J-1, plate 3’000 HeLa cells per well. 
1. Add calcein staining solution as 10X concentrated for a final concentration of 
0.5 µg/ml. A 1X concentrated solution could also be used after removing cell medium. 
2. Incubate at 37°C for 30 min or at RT for 45 min. 
3. (Optional) Wash 1X with 100 µl PBS per well gives better results. 
 
Ethidium homodimer-1 
0. At J-1, plate 3’000 HeLa cells per well. 
1. Add EthD-1 staining solution as 10X concentrated for a final concentration of 1 µM. 
A 1X concentrated solution could also be used after removing cell medium. 
2. Incubate at 37°C for 30 min or at RT for 50 min. 
 
DAPI, calcein and EthD-1 
0. At J-2, plate 3’000 HeLa cells per well. 
1. At J-1, treat control wells with 10 mM CuSO4 added as 10X concentrated solution. 
2. Add staining solution as 10X concentrated for final concentration of 0.5 µg/ml 
calcein, 10 µg/ml DAPI and 1 µM EthD-1. 
3. Incubate at 37°C for 30 min or at RT for 50 min. 
4. Wash 1X with 100 µl PBS per well. 
 
Annexin V conjugate 
0. At J-2, plate 3’000 HeLa cells per well. 
1. At J-1, treat control wells with 10 µM staurosporine added as 10X concentrated 
solution. 
2. Wash 1X with 100 µl PBS per well. 
3. Add 90 µl of annexin-binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2) 
per well. 
4. Add 10 µl of staining solution containing 5X annexin V conjugate stock solution, 
10 µg/ml Hoechst 33342 and 10 µM EthD-1 (final well concentration 50X annexin V 
conjugate, 1 µg/ml Hoechst 33342 and 1 µM EthD-1). 
5. Incubate at RT for 30 min. 
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6. (Optional) Wash 1X with annexin-binding buffer. 
 
LC3B immunostaining 
0. At J-2, plate 3’000 HeLa cells per well. 
1. At J-1, treat control wells with 100 mM chloroquine added as 10X concentrated 
solution. 
2. Fix with 3.7% PFA by removing medium and adding 50 µl PFA per well and 
incubating at RT for 15 min. 
3. Wash 3X with 100 µl PBS per well. 
4. Permeabilize cell membrane with 0.2% Triton X-100 by removing PBS and adding 
50 µl Triton X-100 per well and incubating at RT for 15 min. 
5. Remove Triton X-100 solution and add primary rabbit anti-LC3B antibody at a 
concentration of 1 µg/ml as 50 µl per well. 
6. Incubate 1h at RT. 
7. Wash 3X with 100 µl PBS per well. 
8. Remove PBS solution and add 200X secondary goat anti-rabbit antibody as 50 µl per 
well. 
9. Incubate 1h at RT. 
10. Wash 1X with 100 µl PBS per well. 
11. Remove PBS solution and add 1 µg/ml Hoechst 33342 solution as 50 µl per well. 
12. Incubate 15 min at RT. 
 
 
 
  
  56     
6.3. Segmentation parameters 
Segmentation parameters used with Attovision. 
 
Whole cell/nucleus segmentation 
Processing tab:  
Flat field correction – on  
Select dyes and assign corresponding lamp 
Background subtraction - off 
 
Segmentation tab:  
 Number of steps: 2 
 Step 1: 
  Re-segment 
  Use system ROIs: Polygon 
  Channel A: choose nuclear probe (Hoechst/DAPI) 
  Segmentation setup: 
   Shape: Polygon 
   Image Pre-processing: RB 25X25, Shading 
   Threshold: Automatic, levels: 1 
   Split: Watershed, Erosion Factor: 4 
   Scrap: Min: 50, Max: 2000 
   Options: Dilatation Width: 9 
   ROIs: Whole cell 
 Step 2: 
  Same as Step 1 except from: 
  Options: Dilatation Width: 0 
  ROIs: Nucleus 
 
Dye Thresholds tab:  
 - 
 
Measure tab: 
For whole cell probes, select features to extract. 
For nucleus probes, select Sub Object. Choose corresponding image and select ROIs: 
Nucleus. Choose analysis output. 
 
LC3B assay segmentation 
Processing tab:  
Flat field correction – on  
Select dyes and assign corresponding lamp 
Background subtraction - off 
 
Segmentation tab:  
 Number of steps: 2 
 Step 1: 
  Re-segment 
  Use system ROIs: Cyto-dual 
  Channel A: choose nuclear probe (Hoechst/DAPI) 
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Channel B: Choose LC3B probe (Alexa 647) 
  Segmentation setup: 
   Shape: Dual channel (Exclude Center) 
   Tab A: 
Image Pre-processing: RB 25X25, Shading 
    Threshold: Automatic, levels: 1 
    Split: Watershed, Erosion Factor: 4 
    Scrap: Min: 50, Max: 2000 
    Options: Dilatation Width: 0 
   Tab B: 
Image Pre-processing: RB 25X25 
    Threshold: Automatic, levels: 1 
    Split: Watershed, Erosion Factor: 4 
    Scrap: Min: 50, Max: 5000 
    Options: Dilatation Width: 50 
    ROIs: Cytoplasm 
 Step 2: 
  Re-segment 
  Use system ROIs: Polygon 
  Channel A: choose LC3B probe (Alexa 647) 
  Segmentation setup: 
   Shape: Polygon 
   Image Pre-processing: RB 5X5, Sharpen Hat 
   Threshold: Automatic, levels: 1 + 6-8% 
   Split: Watershed, Erosion Factor: 2 
   Scrap: Min: 2, Max: 25 
   Options: Dilatation Width: 0 
   ROIs: No ROI 
 
Dye Thresholds tab:  
 - 
 
Measure tab: 
Select Sub Object for LC3B probe (Alexa 647). Choose corresponding image (LC3B image) 
and select ROIs: No ROI. Choose analysis output. 
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6.4. VBA Macro information 
These macros reformat outputs of experiments in 96-well analyzed with Attovision and put 
all images in a single folder. They are compatible with Microsoft Office Excel 2004 on 
Windows environment. They won’t work with later version of this software, as VBA 
language is no more supported. 
To start, open Excel file containing the macros (BSF_HCA_Macro.xls). Then, choose 
between “Reformat output” or “Extract images”. 
Reformat output 
 
 
1. Choose the files to analyze by either click on “Choose file” button to select single file 
(e.g. RoiSummary Re-analysis 001) or use “Find files” to enter a keyword (e.g. Re-
analysis) and find all files containing this keyword in a parent folder. The second 
option is useful when several acquisitions or analysis were performed. 
2. Tip the files to reformat in the obtained list. Note “Unselect all” and “Clear list” 
buttons. 
3. Choose options. “Autosave” will automatically save the reformatted file with the 
name of the parent folder. If not selected, a filename will be asked after reformatting. 
“Choose output folder” option let you save all reformatted files in a single folder. If 
not selected, the saving path will be asked for each reformatted files. “Close files after 
processing” will automatically close Excel sheet containing reformatted output. 
4. Format files. Check that you tipped the files to reformat and different options and 
click “Format file” button. If selected, enter the information for saving the files. 
“Status” indicates which file is being processed and when the reformatting is finished. 
 
Notes: Excel sheet limit might be reached (256 columns and 65’536 rows). In this case 
reformatting will be stopped and a warning will appear. To finish reformatting, duplicate the 
analysis file and open it with a text editor. Delete the reformatted part until the beginning of 
the last well reformatted (starting with date and time of acquisition) and run the macro on this 
file. 
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Extract images  
 
 
 
1. Choose experiment folder. Click “Choose Experiment Folder” button to select the 
folder containing all files of your experiment (e.g. 2010-04-21_000). 
2. Choose output folder. Click “Choose Output Folder” button to select or create the 
folder in which all found images will be copied. 
3. Extract images. Click “Extract Images” to find all TIF images contained in the 
experiment folder and copy them in the output folder. “Status” indicates when the 
process is finished. 
 
 
 
